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ABSTRACT
Our work focused on how germ cell DNA is packaged and if it is poised by 
distinctive chromatin to inﬂ uence early embryo development. We studied human 
male and female germ cells and proﬁ led their epigenetic repertoire. Further, we 
asked the question, is misregulation of that poising a common theme observed in 
infertility and aging in sperm? We pursued one part of this question in Chapter 2 
where we investigated the changes in DNA methylation in sperm during the natural 
process of aging. We analyzed sperm from aged-matched donors and found that 
sperm on a global level gained DNA methylation over time, but notably, speciﬁ c 
regions associated with genes linked to neuropsychiatric disorders signiﬁ cantly lost 
DNA methylation in sperm from aged donors. This raised the intriguing question if 
the increase in observed neuropsychiatric disorders in offspring from older fathers 
could be linked to the loss of DNA methylation in sperm of speciﬁ c genes also 
implicated in neuropsychiatric disorders. Further, we asked if abnormalities in 
chromatin are seen in sperm from infertile patients. We tested seven imprinted 
regions in oligozoospermic and abnormal protamine patients and found a correlation 
of DNA methylation abnormalities at the promoters of these genes in infertile 
sperm. Our ﬁ ndings from this study are summarized in a publication detailed in 
Appendix A. Finally, we asked if changes in polyadenylation of transcripts in human 
oocytes could give us an insight into oocyte maturation and early human embryo 
development. We developed a novel bioinformatics tool called PANDA (Chapter 
3) that enabled the analysis of relative polyA changes in transcripts between two
different conditions. One of the advantages of this method is that it can utilize any 
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RNA-seq dataset as long as it has not been biased for PolyA selection. Hence, we 
applied PANDA to the existing RNA-seq dataset, generated by our lab from human 
oocytes and early embryos, and investigated PolyA changes (Chapter 4). Strikingly, 
we were able to identify transcripts in humans that were previously reported to gain 
polyA in oocytes of drosophila and xenopus. We also identiﬁ ed completely novel 
transcripts previously unknown to gain polyA during oocyte maturation. Hence, 
we are the ﬁ rst group to identify these transcripts in human oocytes and embryos. 
Together we hope that by studying the epigenetic setup of germ cells we have 
gained more insight into understanding the regulation of programs critical in early 
embryo development.
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INTRODUCTION
21.1  Epigenetic Information: A Means to Give Instructions to the Genome
Genetic information is stored in the form of DNA in every cell in the nucleus. 
In order to store, organize and orchestrate the use of genetic material, DNA is 
packaged in a higher order structure called chromatin. Chromatin entails DNA that 
is wrapped around histone proteins1 allowing for compaction of  roughly 2 meters 
of DNA into a single 2 µm nucleus for each cell. 
Epigenetics is deﬁ ned as components in the cell that are regulating the 
usage of genetic material and are thought to be instructive as well as heritable. As 
such, any modiﬁ cation on the DNA itself as well as proteins binding to the DNA and 
their modiﬁ cation thereof can be considered epigenetic factors2,3. Chapter 2 of this 
dissertation details the epigenetic modiﬁ cation of cytosine methylation changes in 
context of aging and infertility in human sperm. 
In Chapters 3 and 4, polyadenylation changes in maturing human oocytes 
and early human embryos were investigated. Polyadenylation at RNA transcripts 
is not classically considered an epigenetic modiﬁ cation. However, during a time 
point when the genome is inactive, RNA loaded into cell needs to be regulated 
and instruct and time the genome reactivation. One proposed mechanism involved 
in regulating the reactivation of the genome is the maturation of transcripts and 
proteins necessary for this process. Hence, cytosolic polyadenylation of transcripts 
in the late oocyte development is of key interest in mediating early embryo 
development. In very broad terms, cytosolic polyadenylation can also be regarded 
as an extension of epigenetic regulation. This thesis describes a novel approach at 
investigating polyA changes in maturing human oocytes and early human embryos. 
The ﬁ ndings are detailed in Chapter 3 and Chapter 4 of this dissertation.
31.2  Histone and DNA interactions
Histones are key components in epigenetics, where the DNA wraps around 
these proteins providing tails that can be modiﬁ ed with small chemical groups 
such as a methyl group or an acetyl group. Each histone contains two tetramer 
subunits, comprised of Histone H2A, H2B, H3 and H4 forming a functional octamer 
complex4,5. Once histones are assembled and DNA is wrapped around it, the ﬁ eld 
names this functional unit a nucleosome. Regulation and hence instruction to DNA 
is mediated by chromatin remodeling, histone modiﬁ cations and histone variant 
incorporation6. Nucleosomes can be moved by chromatin remodelers along 
the DNA, or alternatively, can be ejected to provide access to binding sites by 
transcription factors for example.
Transcription factors are DNA binding proteins that recognize sequence 
motifs on the DNA and provide platforms to enable transcription. Chromatin modiﬁ ers 
such as histone methyl transferases, for example SET1 H3K4 methyl-transferase, 
mediate this process. On the ﬂ ip side of transcriptional activation, transcriptional 
repression is also a key element in regulating mRNA abundance. Hence, enzymes 
and proteins are needed to remove an activating mark such as H3K4me3. Two 
prominent mechanisms have been demonstrated in removing H3K4me3. One 
mechanism involves a H3K4 demethylase such as MLL1/2 that can remove the 
methyl groups at the H3K4 residue in a stepwise process, reducing tri-methyl 
to di-methyl, mono-methyl and eventually unmethylated state of H3K4. Another 
mechanism involves a histone chaperone or a nucleosome remodeler, removing or 
ejecting the histone with its modiﬁ cation from the DNA thus enabling an unmodiﬁ ed 
histone to take the place of the removed histone. Transcriptional repression is not 
only mediated by histone modiﬁ cations but also by DNA modiﬁ cations7. 
41.3  DNA Methylation 
Besides modiﬁ cations to histone tails, chemical modiﬁ cations to the 
DNA are also well established in regulating and maintaining cellular identity. 
One of the most predominant modiﬁ cations of DNA in vertebrate animals and 
plants is DNA  methylation at the 5th carbon of the cytosine base (DNAme). 
The coordinated placement of DNAme in vertebrates is mediated by enzymes 
called DNA methyltransferases (DNMTs). DNMTs are distinguished into two 
important subclasses in the cell. DNMT1 plays the role of the maintenance DNA 
methyltransferase that recognizes hemi-methylated DNA after replication and 
ensures the methylation of the cytosine in the newly synthesized DNA strand. 
DNMT1 is thought to drive the majority of DNA methylation in vertebrate cells. The 
second subclass of DNMTs are considered to be de novo DNA methyltransferases, 
DNMT3a and DNMT3b. As the name of the subclass suggests, DNTM3s place 
cytosine methylation onto unmethylated CpG dinucleotides as well as in the 
sequence context of CHH or CHG8,9. 
It has been shown that DNAme is strongly correlated with inactive parts 
of the genome and that promoter methylation is incompatible with transcriptional 
activity10-12. A notable exception has been recently published from our lab in adult 
germ stem cells13 where gametogenesis genes can be transcribed in the presence 
of DNA methylated promoters, but it is considered to be a notable exception to the 
rule. Another important aspect of DNAme is that it is inheritable and may instruct 
the accessibility to the genetic information for the transcription machinery14-16. 
The property of epigenetic information to regulate cellular functions such as 
proliferation, differentiation and inheritance illustrates its importance and explains 
the broad interest in studying its function. Inappropriate alterations and wrongful 
deposition, or a lack thereof, of epigenetic marks such as DNAme may lead to 
diseases such as cancer17 and pose a risk for developmental disorders18. This 
5thesis work explores how DNAme is altered in aging human sperm in infertile 
patients and how sperm samples should be thoroughly and robustly handled to 
eliminate any somatic cell contamination from the DNAme analysis. 
1.4  DNA Methylation in Context of Germ Cells
DNA methylation plays an important role in compacting and organizing the 
genome. Somatic cells reportedly have bulk CpG DNA methylation levels of ~70% 
of all cytosines. In contrast, sperm is even more hypermethylated, averaging ~90% 
CpG methylation in the genome. The contrast of DNAme mesas versus canyons in 
the sperm genome is quite remarkable and has been extensively discussed before19. 
The comparatively few hypomethylated CpGs in the sperm genome can be found 
at poised promoters and imprinted loci of developmentally important genes19. It has 
been reported that DNAme aberrations at imprinted loci were detected in sperm 
from infertile patients20-23. Part of my thesis work was my involvement in writing 
software to identify aberrant loci of DNAme in infertile patients23. 
Another key interest in the Carrell and Cairns lab is the effect of aging on 
the DNAme landscape in germ cells. As mentioned before, the DNA of sperm is 
very hypermethylated. We were interested in the question, what happens to the 
distinct DNAme landscape in human sperm of aging donors? In collaboration with 
Tim Jenkins from the Carrell lab, we had the unique opportunity to investigate 
DNAme changes of sperm during the process of aging in healthy human donors. 
Importantly, we were able to age-match sperm from donors as well as follow sperm 
from individuals over an extended period of time (8-15 years). In summary, sperm 
kept the overall very deﬁ ned and stable DNAme landscape with increased age; 
however, DNA hypomethylation was observed in aged sperm at interesting gene 
candidates that have been implicated in neuropsychiatric disorders24,25. In the light 
of recent publications detailing sperm’s contribution to early embryo development 
6other than just delivering the appropriate amount of DNA, epigenetic modiﬁ cations 
such as DNAme are gaining more and more interest as potential drivers for early 
embryo development19,26. In addition, recent reports suggest that hypomethylated 
regions with high CpG density also appear to drive nucleosome retention26. 
It is worth mentioning that human sperm exchanges the majority (>85%) of its 
histones with protamines. This exchange is thought to allow the sperm genome 
to be extremely tightly compacted27,28. Notably, the histones that are retained in 
the sperm genome exhibit histone modiﬁ cations and are placed at regions in the 
genome that lack DNAme. This in turn raises the question of whether the changes 
observed in DNAme in aging sperm are associated with aberrant deposition or 
retention of histones at these regions. Taken together, our data strongly support 
the hypothesis that the sperm epigenome is not only well suited to facilitate mature 
sperm function, but that it may also contribute to events beyond fertilization29. My 
contributions to this publication were the analysis of DNAme changes during this 
study and the development of software to study sperm subpopulations. These 
ﬁ ndings were published in the journal PLOS Genetics29 and are included in this 
dissertation as Chapter 2.
Finally, large retrospective epidemiological studies of fathers experiencing 
famine recently suggested that alterations to the sperm epigenome might have an 
effect on disease frequency with late onsets such as heart disease and diabetes30,31. 
Interestingly, these ﬁ ndings are supported by animal models suggesting a link of 
environmental inﬂ uences onto the epigenome of sperm32. In summary, the sperm 
epigenome plays an important part in early embryo development as well as late 
onset diseases. It has the potential to confer properties for transgenerational 
inheritance and as such is of great importance and needs to be studied in great 
detail. 
71.5  DNA Demethylation
As mentioned previously, mature sperm cells are hypermethylated in 
comparison to most somatic cells. In contrast, oocytes are hypomethylated 
in comparison to both sperm cells and somatic cells with an average CpG 
methylation of ~40%. Upon fertilization, both the maternal and the paternal pro-
nucleus lose global DNA methylation levels (Figure 1.1). A notable difference is the 
active DNA demethylation in the paternal pro-nucleus in mammals versus passive 
DNA demethylation in the maternal pro-nucleus. The active DNA demethylation 
is mediated through ten-eleven enzymes (Tet enzymes) that oxidize the 5mC 
to 5-hydroxymethylcytosine (5hmC, Figure 1.2). The modiﬁ ed cytosine, 5hmC, 
can then be further oxidized to 5-formyl-cytosine (5fC) and 5-carboxyl-cytosine 
(5caC). The latter two cytosine modiﬁ cations are known targets of TDG (Thymine-
DNA glycosylase), which can recognize both 5fC and 5caC as a mismatch with 
guanosine on the opposite strand. TDG will cleave the base, leaving an abasic 
site for the base excision repair machinery (BER) to ﬁ x. BER is shown to repair the 
abasic site with a cytosine, completing the complicated cycle of 5mC removal. It 
is important to point out that active induced deaminase (AICDA/AID), an enzyme 
most studied in context of B-cell maturation, was also shown to remove 5mC on 
a global level in zebraﬁ sh. While AICDA is not essential and most likely not the 
preferred for the cell to remove 5mC from the genome, it is worth mentioning that 
AICDA is overexpressed in a lot of cancers that also exhibit a DNA hypomethylated 
phenotype. AICDA functions as a cytosine deaminase, removing the amine group 
at the fourth carbon in cytosine, effectively converting 5mC to thymine. This in turn 
will also create a T:G mismatch which can be ﬁ xed by either TDG or MBD4 (Methyl-
binding-domain containing protein 4) by excising the thymine base creating an 
abasic site as a result. As mentioned before, this abasic site is recognized by 
the BER machinery, which targets the abasic site and replaces it with a cytosine 
8(Figure 1.2).
1.6  Protection of the Maternal Pro-nucleus from Active DNA Demethylation
A key task for the zygote is to ensure that active DNA demethylation 
primarily targets the paternal genome. The maternal genome contains imprinted 
loci, regions of regulatory DNA elements that are hypermethylated in the maternal 
genome and hypomethylated in the paternal genome (Figure 1.3). A protein called 
DPPA3/Stella/PGC7 has been shown to bind these maternally imprinted loci by 
binding to histones marked by H3K9me2 histone modiﬁ cation. DPPA3binding 
prevents Tet3, the active DNA demethylase, from binding and demethylating. It 
has been postulated that the maternal genome is only targeted by Stella since the 
paternal genome by and large lacks histones due to its packaging by protamines. 
Remarkably, we found DPPA3 to be in the top 25 transcripts that receive the most 
polyadenylation during human oocyte maturation. This ﬁ nding is described in more 
detail in Chapter 4 of this dissertation.
1.7  DNA Methylation and Transgenerational Inheritance
The previous section already touched upon the notion that there is a strong 
interplay of histones with DNA and DNA methylation. In fact, non-coding RNAs 
also play and important role in deposition and maintenance of DNAme. As seen 
in Figure 1.1, DNA demethylation is signiﬁ cantly reduced upon fertilization in 
both the maternal and paternal genome. It is, however, reestablished after the 
embryo implants into the uterus wall of its mother in the epiblast stage (~E6.5). 
A second wave of DNA demethylation was shown to occur during the maturation 
of primordial germ cells (PGCs) to mature germ cells such as oocytes and sperm 
cells. Consequently, any changes in DNAme that persist in the offspring germ 
9cells need to survive two rounds of DNA demethylation. A possible mechanism 
by which “memory” of DNA methylation status is thought to occur comprises a 
combination of histone modiﬁ cations and non-coding RNA. For example, histone 
H3K9me3 modiﬁ cations are strongly correlated with DNAme. Proteins such as 
HP1 (Heterochromatin Protein 1) can both bind DNAme with the interaction of 
MeCP2 and recruit SUV39H1, a histone H3K9 methyltransferase. Non-coding 
RNAs (ncRNAs) have been shown to either directly recruit DNA methyltransferases 
to their site of expression33 or to recruit repressive histone modiﬁ cations to 
sites of repression. For example, it is well recognized in the ﬁ eld that ncRNAs 
from loci such as XIST or Hox can recruit the PRC2 machinery34,35. The PRC2 
complex is responsible for depositing H3K27me3, a histone mark also associated 
with repressive chromatin. Targeting H3K9me3 and, by association, DNAme to 
imprinted loci, ncRNAs from the Igf2r and Kcnq1 loci have been shown to recruit 
EHMT2, a H3K9me3 methyltransferase36-38, to the site of imprinting. In summary, 
regulation of DNA methylation is part of complex network of regulation, involving 
not only enzymes directly responsible for DNAme deposition but also ncRNA and 
histone modiﬁ cation pathways. Chapter 2 and the Appendix B in this thesis touch 
upon the DNAme in sperm and their regulation. Notably, we also set out to test 
the robustness of DNAme in germ cells by purposefully altering their DNAme 
levels with a drug called 5-aza-cytidine (5azaC). 5azaC blocks DNMT function by 
irreversible binding, rendering DNMTs inactive once engaged to 5azaC. We plan 
to test transgenerational inheritance of altered DNAme levels but the experiments 
related to this story are not ﬁ nished as of yet.
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1.8  Polyadenylation of RNA in Cells
A fundamental process in the cell is transcription, which copies genes in 
the DNA, creating RNA molecules that may be used as templates for protein 
synthesis. Importantly, the stability and hence the half life of these copies need 
to be tightly regulated in order to ensure turn over and allow for adaptations 
to a changing environment 39,40. The regulation of RNA stability and, in case of 
mRNA, the translation of such into protein is considered a posttranscriptional 
process. A key posttranscriptional change at RNAs involves a process known as 
polyadenylation (polyA) that extends about 50-300 adenine nucleotides at the 
3’ prime end of the transcript. PolyA changes at mRNAs have been implicated 
to stabilize transcripts41,42 as well as promote translational efﬁ ciency43,44. It has 
been shown that the default mode for RNA biogenesis is the co-transcriptionally 
polyadenylation in the nucleus45. However, a notable exception in development of 
maturing oocytes is the mechanism of cytosolic polyadenylation46-49. 
Brieﬂ y, transcripts that are used for late stage oogenesis or in the early 
developing embryo, a period in time where the genome is transcriptionally inactive 
and no new RNA transcripts are generated (Figure 1.4), are shown to skip nuclear 
polyadenylation and instead gain polyA in the cytosol. The regulatory element 
involved in mediating cytosolic polyadenylation, CPE (cytosolic polyadenylation 
element), has been shown to be part of the primary RNA sequence50-52. Further, 
binding proteins called CPEBs (cytosolic polyadenylation element binding protein) 
can recognize the CPE allowing for accurate timing of cytosolic polyadenylation 
upon their phosphorylation47,50,51,53,54. 
Most notably, the physiological process of cytosolic polyA gain has an 
essential role during the maturation of oocytes and in early embryos, before 
embryonic genome activation (EGA). EGA is the key point in embryonic 
development, when the genome in the embryo becomes transcriptionally active, 
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producing newly synthesized RNAs with new polyA tails. At these developmental 
stages, cytosolic polyA has been extensively studied in Xenopus and Drosophila 
oocytes and early embryos 46,49,51,52,55-59. 
The polyA tail length is controlled by several enzymes that act on the 3’UTR 
by adding (PolyA Polymerase, PAP) or removing (PolyA Ribonuclease, PARN) 
adenenine ribonucleotides. After transcription, the RNA messages are transported 
out of the nucleus where they gain a longer polyA tail in the cytoplasm (Figure 
1.5). This regulation requires a sequence element to be present upstream of the 
polyA site know as the cytosolic polyadenylation element (CPE). This CPE has 
a sequence motif of 4-6 Ts, followed by 1-2 As and a T. Importantly, CPE binding 
proteins (CPEBs) exist to recognize the aforementioned sequence motif and serve 
as the platform for other proteins such as PAP and PARN to bind. In the cytoplasm, 
protein kinases such as calmodulin-dependent kinase 2 alpha (CAMK2α)60,61 and 
aurora A kinase (AURKA/Eg2)62 are known to target CPEB and phosphorylate 
tyrosine residue 174 which in turn changes the balance of the PAP/PARN complex 
at the 3’ UTR in favor of the PAP activity (Figure 1.5). Thus, 3’ elongation of polyA 
can be observed after phosphorylation of CPEB. The increased polyA tail at the 
mRNA then promotes higher translational efﬁ ciency, resulting in an increase in 
protein synthesis of this particular message. Importantly, the messages involved 
in maturing oocyte and preparing the early embryo development need to also 
be negatively regulated in order to stop the production of proteins and conserve 
energy. This will ensure that enough nutrients and energy remain available for the 
embryo to attach to the uterus wall and develop a placenta. While the process 
of cytosolic polyA has been studied in great detail in Xenopus and Drosophila, 
a transcript wide analysis of polyA changes at that the stage of oogenesis and 
early embryo development in mouse or human remains elusive. Here we show 
a transcript wide analysis of polyA changes in human oocytes and early human 
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embryo with details discussed in Chapters 3 and 4.
1.9  Dissertation Overview
Overall, our goal was to study the epigenome of male and female germ cells 
in the context of aging and infertility for sperm cells and in a normal physiological 
context for human oocytes. Chapter 2 details my contributions in understanding 
the effect of aging on the sperm methylome. I wrote software and analyzed 
sperm cells regarding subpopulations and detailed changes in DNAme patterns 
in aged donors. Our ﬁ ndings suggest a link between hypomethylated regions in 
aged sperm from human donors and neuropsychiatric disorders.  Future studies 
possibly involving mouse models may be able to show a causal link. Right now, 
loci-speciﬁ c DNA hypomethylation in sperm of aged donors is only correlated with 
possible negative effects for the offspring.
Appendix A describes human sperm DNA methylation aberrations in 
infertile patients. Similarly to Chapter 2, I wrote software to analyze targeted 
bisulﬁ te sequencing for candidate loci. The ﬁ ndings of this publication suggest a 
correlation of DNAme aberrations at developmentally important loci. It is important 
to note that this is not a causal link, but it suggests that improper DNAme levels at 
developmentally important regions may have an inﬂ uence on male fertility. 
Appendix B details a critical improvement to the sperm preparation protocol 
in order to abolish DNAme contaminations from somatic cells. It is paramount 
that only pure sperm samples are compared to each other in order to ensure 
appropriate conclusions. My contribution was the development of a robust and 
stringent sperm puriﬁ cation protocol that was tested and succeeded with the 
deliberate contamination of sperm cells with white blood cells. The results and the 
detailed protocol can be found in Appendix B.
In Chapters 3 and 4, we explore transcriptional changes of human oocytes 
13
and early human embryos. The unique aspect of our work is to understand more 
about the connection between oocytes that are transcriptionally inactive and 
RNA regulation during the ﬁ nal stages of oocyte maturation. Notably, oocytes are 
extremely difﬁ cult to study since the material is very limited in amount. However, we 
generated RNAseq datasets that are unbiased for the polyA status of the transcripts 
present in oocytes. We developed a software tool called PANDA, detailed in 
Chapter 3, which is capable of detecting polyA changes of transcripts in both oocyte 
maturation as well as early embryo development. The software methods paper is 
written as a manuscript ready for submission and its content is part of Chapter 3. 
The results from applying PANDA towards the human oocyte and human early 
embryo data are part of Chapter 4. We were able to identify key transcripts that 
are subjected to polyA gain with importance in oocyte maturation and early embryo 
development. We also list transcription factors and DNA binding proteins that have 
not been previously shown to be important during that developmental time point. 
Our ﬁ ndings have been documented in Chapter 4, which is currently a manuscript 
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2CHAPTER 2
AGE-ASSOCIATED SPERM DNA ALTERATIONS: POSSIBLE IMPLICATIONS 
IN OFFSPRING DISEASE SUSCEPTIBILITY
Reprinted with permission from Plos Genetics. Jenkins TG, Aston KI, Pﬂ ueger C, 
Cairns BR, Carrell DT (2014) Age-associated sperm DNA alterations: possible 
implications in offspring disease susceptibility. Plos Genetics 10(7): e1004458.
Chapter 2 is a published article. My contribution to this work involved performing 
the base pair resolution DNA methylation analysis from the  samples that were 
sequenced using the MiSeq technology.
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Abstract
Recent evidence demonstrates a role for paternal aging on offspring disease susceptibility. It is well established that various
neuropsychiatric disorders (schizophrenia, autism, etc.), trinucleotide expansion associated diseases (myotonic dystrophy,
Huntington’s, etc.) and even some forms of cancer have increased incidence in the offspring of older fathers. Despite strong
epidemiological evidence that these alterations are more common in offspring sired by older fathers, in most cases the
mechanisms that drive these processes are unclear. However, it is commonly believed that epigenetics, and specifically DNA
methylation alterations, likely play a role. In this study we have investigated the impact of aging on DNA methylation in
mature human sperm. Using a methylation array approach we evaluated changes to sperm DNA methylation patterns in 17
fertile donors by comparing the sperm methylome of 2 samples collected from each individual 9–19 years apart. With this
design we have identified 139 regions that are significantly and consistently hypomethylated with age and 8 regions that
are significantly hypermethylated with age. A representative subset of these alterations have been confirmed in an
independent cohort. A total of 117 genes are associated with these regions of methylation alterations (promoter or gene
body). Intriguingly, a portion of the age-related changes in sperm DNA methylation are located at genes previously
associated with schizophrenia and bipolar disorder. While our data does not establish a causative relationship, it does raise
the possibility that the age-associated methylation of the candidate genes that we observe in sperm might contribute to
the increased incidence of neuropsychiatric and other disorders in the offspring of older males. However, further study is
required to determine whether, and to what extent, a causative relationship exists.
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Introduction
The effects of advanced paternal age have only recently become
of interest to the scientific community as a whole. This interest has
likely arisen as a result of recent studies that suggest an association
with increased incidence of diseases and abnormalities in the
offspring of older fathers. Specifically, offspring sired by older
fathers have been shown to have increased incidence of
neuropsychiatric disorders (autism, bipolar disorder, schizophre-
nia, etc.) [1–3], trinucleotide repeat associated diseases (myotonic
dystrophy, spinocerebellar atixia, Huntington’s disease, etc.) [4–7],
as well as some forms of cancer [8–11]. Though these are
intriguing data, we know very little about the etiology of the
increased frequency of diseases in the offspring of older fathers.
Among the most likely contributing factors to this phenomenon
are epigenetic alterations in the sperm that can be passed on to the
offspring.
These studies are in striking contrast to the previously held
dogma that the mature sperm are responsible only for the
safe delivery of the paternal DNA. Intriguingly, with increased
investigation has come mounting evidence that the sperm
epigenome is not only well suited to facilitate mature gamete
function but is also competent to contribute to events in embryonic
development. It has been established that even through the
dramatic nuclear protein remodeling that occurs in the developing
sperm, involving the replacement of histone proteins with
protamines, some nucleosomes are retained [12]. Importantly,
histones are retained at promoters of important genomic loci
for development, suggesting that the sperm epigenome is poised
to play a role in embryogenesis [12]. In addition, recent reports
suggest that hypomethylated regions with high CpG density
also appear to drive nucleosome retention [13]. Similarly, DNA
methylation marks in the sperm have been identified that likely
contribute to embryonic development as well [12,14]. These data
strongly support the hypothesis that the sperm epigenome is not
only well suited to facilitate mature sperm function, but that it also
contributes to events beyond fertilization.
Looking past fertilization and embryogenesis, sperm appear to
contribute to events manifesting later in life. The remarkable claim
that sperm, independent of gene mutation, may be capable of
affecting phenotype in the offspring was initially proposed as a
result of large retrospective epidemiological studies observing
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changes in the frequency of diseases in the offspring of fathers who
were exposed to famine conditions in the early 19th century
[15,16]. Recently, many studies utilizing animal models have
discovered similar patterns that comport with the epidemiological
data. Specifically, in male animals fed a low protein diet, offspring
display altered cholesterol metabolism in hepatic tissue [17].
However, the etiology of this phenomenon is poorly understood.
Despite this, there are multiple likely candidates that may drive
these effects, such as DNA methylation.
Methylation marks at cytosine residues, typically found at
cytosine phosphate guanine dinucleotides (CpGs), in the DNA are
capable of regulatory control over gene activation or silencing.
These roles are dependent on location relative to gene architecture
(promoter, exon, intron, etc.). Since these heritable marks are
capable of driving changes that may affect phenotype, they
represent a possible mechanism to explain the increased disease
susceptibility in the offspring of older fathers. Additionally, in both
sexes, aging alters DNA methylation marks in most somatic tissues
throughout the body. In one of the first large studies to address
the question of age-associated methylation alterations, Christensen
et al. identified over 300 different CpG loci with age-associated
methylation alterations in many tissues [18]. One recent study
compared age-associated DNA methylation alterations in blood,
brain, kidney and muscle tissue and identified both common
and unique methylation alterations between different tissues [19].
Additionally, recent work suggests that DNA methylation can be
used to predict the age of an organism based on tissue methylation
profiles [20]. This study also supports previous reports which
identify global hypomethylation as a hallmark of aging in most
somatic tissues [21]. Because of its prevalence in other cell types,
age-associated DNA methylation alteration is likely to occur in
sperm as well. In further support of this idea is work demonstrating
that frequently dividing cells typically have more striking
methylation changes associated with age than do cells which
divide less often [22]. In this study we have analyzed the age
associated sperm DNA methylation alterations that are common
among the individuals in our study population to determine
the magnitude of sperm DNA methylation changes over time and
whether specific regions are consistently altered with age.
Results
Our study includes 17 sperm donors (of known fertility) that
collected an ejaculate in the 1990’s. These donors were asked to
provide an additional semen sample in 2008, enabling the
evaluation of intra-individual changes to sperm DNA methylation
with age. These samples are referred to as young (1990’s
collection) and aged (2008 collection) respectively. The age
difference between each collection varied between 9 and 19 years,
and the age at first collection (‘‘young’’ sample) was between 23
and 56 years of age. Table 1 describes the donor demographics
within both categories.
Global methylation analysis
To assess global methylation in the samples in question we
performed pyrosequencing analysis of long interspersed elements
(LINE), a commonly used tool for the analysis of global
methylation in many tissues [23,24]. We identified significant
global hypermethylation with age in sperm DNA as previous data
from our lab suggests (Figure 1) [25]. Specifically, there was
significant hypermethylation with age based on a paired analysis
(p = 0.028) or by stratifying the samples by age alone and
performing linear regression analysis (p = 0.0062).
Array analysis
In addition to the global analysis, we performed a high
resolution (CpG level) analysis of methylation alterations with
age. To perform this we utilized Illumina’s Infinium Human-
Methylation 450K array. Each sample was hybridized and
analyzed on an array and the results were compared to detect
changes in methylation that are consistent with age. We utilized a
sliding window analysis, coupled with regression analysis (average
methylation at identified window versus the age at collection) as an
additional filter (any window whose regression p-value was .0.05
was excluded from downstream analysis), to compare changes that
are common between paired samples. A Benjamini Hochberg
corrected Wilcoxon Signed Rank Test FDR of ,=0.0001 and
an absolute log2 ratio .=0.2 (effectively a change in methylation
of approximately 10% or greater) was used as our threshold
of significance. Raw FDR values have been transformed for
visualization in figures and reference in this text ((210 log10
(q-value FDR)), such that a transformed FDR value of 13=
0.05, 20= 0.01, 25= 0.003, 30= 0.001, and 40= 0.0001. With
this approach we have identified multiple age-associated intra-
individual regional methylation alterations that consistently
occur within the same genomic windows in most or all of the
donors screened. Specifically, we identified a total of 139 regions
that are significantly hypomethylated with age (Log2 ratio #20.2)
and 8 regions that are significantly hypermethylated with age
(Log2 ratio $0.2; Table S1). The average significant window is
approximately 887 base pairs in length and contains an average
of 5 CpGs with no fewer than 3 in any significant window. Of
the 139 hypomethylated regions, 112 are associated with a gene
(at either the promoter or the gene body), and of the 8
hypermethylated regions 7 are gene associated. The 8 hyper-
methylated regions that were found did change in all donor
samples, however they did not increase DNA methylation
levels beyond 0.1 fraction methylation. In one case we identified
3 significantly hypomethylated windows within a single gene
(PTPRN2). Thus there were a total of 110 genes with age-
associated hypomethylation.
Author Summary
There is a striking trend of delayed parenthood in
developed countries due to secular and socioeconomic
pressures. As a result, physicians commonly consult with
concerned patients inquiring about the impact of ad-
vanced age on their ability to conceive healthy offspring.
The concern has more frequently surrounded the effects of
advanced maternal age, but recent evidence suggests
negative effects of advanced paternal age as well.
Specifically, studies have demonstrated increased inci-
dence of neuropsychiatric and other disorders in the
offspring of older males. In this study we have investigated
a commonly hypothesized mechanism for this effect,
namely sperm DNA methylation alteration. Our data
indicate that specific genomic regions of DNA methylation
are commonly altered with age, suggesting that some
regions of the sperm genome are more susceptible than
others to age-related epigenetic changes. Importantly, a
significant portion of these alterations occur at genes
known to be associated with schizophrenia and bipolar
disorder, both of which display increased incidence in the
offspring of older fathers. These data will be important in
driving future studies aimed at determining the impact
that these methylation alterations may have on offspring
health and will thus enable couples at advanced repro-
ductive ages to be more informed of possible risks.
Sperm DNA Methylation and Aging
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A previous report analyzing multiple somatic tissues suggests
that the magnitude of DNA methylation alterations that occurs
with age is fairly subtle with an average percent change per year
(measured as slope) at a single CpG of approximately 0.05% to
0.15% [19]. Our data, while still subtle, suggest that there may be
a stronger effect of age on the methylation alterations in sperm
compared with somatic cells. Briefly, in the four tissues screened
by Day et al. (blood, brain, kidney and muscle) they identified a
total of 8 individual CpGs with a methylation change per year
of .0.4% and a single CpG with a yearly change of .0.5%. By
comparison, our data have revealed a total of 26 genomic windows
(not just individual CpGs) whose average fraction methylation
change is .0.4% per year and 13 genomic windows with
an average fraction methylation change per year of .0.5%
(Figure 2A–B). Specifically in hypermethylated regions, the
average fraction methylation change was 0.304% per year
(ranging from 0.08% to 0.95% per year). In hypomethylated
regions the average fraction methylation change was 0.279% per
year (ranging from 0.08% to 0.92% per year). Considering the
entire reproductive lifespan of a male, it is not unreasonable to
anticipate an average change of 10–12% at these significantly
altered regions. Importantly, these alterations all occur in windows
with an average initial fraction methylation of ,0.6 at the first
collection and the majority (67% of altered regions) are also
considered to have intermediate methylation based on conven-
tional standards (fraction DNA methylation levels between 0.2 and
0.8; Figure 2B). Despite the increased magnitude of age-associated
alterations in sperm when compared to somatic cells these changes
are still quite subtle when considering the possible biological
impacts at the 119 regions of age-associated alteration that are
found at genes (gene bodies, promoters). Gene promoters were
defined based on Illumina’s array annotation, in general these fall
within 1000 bps of the associated gene.
The significant loci identified in our analyses are located at
various genomic features. The majority of regions that undergo
age-associated hypomethylation occurred at CpG shores, whereas
hypermethylation events are more commonly associated with
CpG islands, and these differences are significant in both cases
(p = 0.0015 and p=0.0056 respectively; Figure 2C). It should be
noted that while we did observe these significant changes there are
slight differences in the baseline fraction methylation at islands and
shores between regions with hypomethylation events and those
with hypermethylation events (at the highest an absolute fraction
methylation change of 0.16). We additionally analyzed the co-
localization of windows of age associated methylation alterations
with known regions of nucleosome retention in the mature sperm,
as well as regions where specific histone modifications are found
based on previous work from our laboratory [12]. We found that
approximately 88% of regions that are hypomethylated with age
are found within 1 kb of known nucleosome retention sites in the
mature sperm (Figure 2D). Interestingly, loci that are hypermethy-
lated with age are far less frequently found in regions of histone
retention, with only approximately 37.5% being associated with
sites where nucleosomes are found, though there are only 8 regions
of significance on which to base this analysis. This difference was
significant based on a fisher’s exact test (p = 0.002). Similarly, 23%
of loci with age-associated hypomethylation are associated
with H3K4 methylation and 45.3% are associated with H3K27
Table 1. Donor demographics.
Parameter Young (6SEM) Aged (6SEM) Significance
Age 37.7 (62.12) 50.3 (62.1) N/A
Volume 3.78 (60.46) 2.85 (60.45) p = 0.0142
Million/ml 125.4 (69.16) 145.56 (615.57) P.0.05
Total count 434.32 (653.67) 424.67 (688.69) P.0.05
Total motile 63.38 (61.64) 61.25 (64.34) P.0.05
% live 69.08 (61.47) 61.0 (63.93) P.0.05
doi:10.1371/journal.pgen.1004458.t001
Figure 1. Pyrosequencing results for the LINE-1 global
methylation assay. (A) The box plot depicts significantly increased
average global methylation with age based on a non-paired t-test of all
samples#45 (n = 17) years of age vs. all samples.45 (p = 0.001; n = 17).
Global methylation was also stratified based only on age at the time of
collection for each sample from all 17 donors (a total of 34 samples with
each donor represented twice). (B) Linear regression analysis confirmed
the significant increases in global sperm DNA methylation with age
(p = 0.0062).
doi:10.1371/journal.pgen.1004458.g001
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methylation. The same co-localization is very rare with hyper-
methylation events (p = 0.0107). Additionally, we analyzed chro-
mosomal enrichment of these marks to determine if there are
specific chromosomal regions that are more susceptible to age-
related methylation alterations. We found a random distribution of
significant age-associated methylation alterations throughout the
entire genome with what appears to be enrichment at telomeric
and sub-telomeric loci, however this apparent enrichment failed to
reach significance (Figure 3).
Sequencing analysis
To confirm our array data we selected 21 regions found to be
significant by our array analysis and subjected them to targeted
bisulfite sequencing (on the MiSeq platform) to confirm that
the CpGs tiled on the array reflected the entire CpG content
within the windows of interest. Specifically, we amplified via PCR,
bisulfite converted DNA from each donor (young and aged
collections). The PCR was designed to produce amplicons of
approximately 300–500 bp that were located within 21 of the
regions of significant methylation alteration we identified by array.
Our depth of sequencing was quite robust with an average of 2,252
(SE 6371.6) reads per amplicon in each sample. The minimum
number of average reads for any one amplicon was 313. In 20 of
the 21 gene regions that were analyzed, the array and MiSeq data
were similar in both direction and relative magnitude (Figure 4A).
In the one case that did not show a similar trend (hypomethylation
with age by array and no change by MiSeq) the amplicon was
outside the region of the two CpGs that drove the significance of
the window. When comparing the methylation of the approxi-
mately 300 bp amplicon to the CpG tiled on the array in that
same region only, and not the array CpGs over the entire
1000 bp window, the data are in agreement. Taken together,
the sequencing run confirmed that our array data is a good
representation of the methylation status at all CpGs in our regions
of interest.
Independent cohort analysis at identified regions of
interest
To confirm that the sites identified on the array were not only
altered in the samples we investigated, but that these loci are
also altered with age in the sperm of non-selected individuals in
the general population, we have performed an analysis on an
independent cohort of individuals from two age groups: young,
defined as ,25 years of age (n = 47), and aged, defined as $45
years of age (n = 19). Average age in the young cohort was 20.46
years of age (SE 60.18), and in the aged cohort 47.71 years of age
(SE 60.77). We performed a multiplex sequencing run on sperm
DNA from these individuals to probe for 15 different regions of
interest that were identified with the array data. Briefly, we PCR
amplified 15 regions (using bisulfite converted DNA) from each
Figure 2. (A) The magnitude of alterations in terms of amount of change per year (reported as slope magnitude) for all regional
changes that occur at CpG islands, shores and outside of these regions (other). Average alterations per year were approximately 0.281%.
(B) Average b-values for all significant windows (hypomethylation and hypermethylation events) for both aged and young. Average decrease in b-
value was approximately 3.9% for intra-individual hypomethylation events and 3.2% for hypermethylation events. (C) the percent of regions of
hypermethylation and hypomethylation at CpG islands, shores and outside of these regions (Other). Hypermethylation events were significantly more
enriched at islands than were hypomethylation events based on a fisher exact test (p = 0.0056). Hypomethylation events were significantly more
enriched at shores in comparison to hypermethylation events (p = 0.0015). Hypermethylation and hypomethylation events were similarly enriched in
regions outside of islands and shores. (D) We also investigated the co-localization of nucleosomes (every region of known histone retention) as well
as histone modifications (H3K4 methylation, and H3K27 methylation) with our windows of interest. Hypermethylation events were less frequently
associated with all retained histones (nucleosomes) or loci with H3K27 methylation when compared to hypomethylation events based on Fisher’s
Exact Test (p = 0.002; p = 0.0107). Co-localization of hypermethylation or hypomethylation events with H3K4 methylation was statistically similar.
doi:10.1371/journal.pgen.1004458.g002
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individual (47 young, and 19 aged). The PCR was designed
to produce amplicons of approximately 300–500 bp that were
located within 15 regions of significant methylation alteration
identified by array. Our depth of sequencing was, again, quite
robust with approximately 3,645 (SE 6853.4) reads per amplicon
in each sample with a minimum average number of reads for any
one amplicon of 263. From these data we have confirmed that
these genomic regions clearly undergo age-associated methylation
alterations (Figure 4B). Interestingly, the average magnitude of
alteration is also much higher in our independent cohort than
in our initial paired donor sample study (approximately 2.2
times greater on average). This is particularly remarkable when
considering that the average age difference in the independent
cohort study was 27.2 years, effectively 2.3 times greater than the
average age difference of 12.6 years seen in the paired donor
analysis. This further supports our regression data in the paired
Figure 3. (A) Chromosomal loci of each altered region are depicted where blue marks represent hypomethylation events and red
marks hypermethylation events. (B) The Correlation Maps app on the USeq platform was used to locate any specific chromosomal enrichment of
altered methylation windows. Specifically, the application called any 100 kb region where at least two significantly altered methylation marks were
found. All called chromosomal enrichment regions are displayed though none were found to be significantly enriched over the background.
doi:10.1371/journal.pgen.1004458.g003
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donor study, which generally suggest a linear relationship of
methylation alterations with age at most of the identified genomic
loci.
Single molecule analysis of targeted sequencing
To address the question of the dynamics of sperm population
changes associated with the approximately 0.281% change per
year identified in this study we subjected our next generation
sequencing data from the paired donor samples to a novel analysis
where we compared the sperm population shifts between the
young and aged samples. Because the MiSeq platform produces
data for each single nucleotide sequence (each representing
the methylation status in a single sperm) we are able to determine
average methylation at each region for all of the amplicons
analyzed. We identified 3 general patterns in methylation profile
population shifts that resulted in the age–associated methylation
Figure 4. (A) Comparison of MiSeq results to our array results at 21 representative regions. Because beta-values and fraction methylation
are generated in a different manner (array vs. sequencing respectively) they are not directly comparable. For this reason we compared the fractional
difference for each loci and each technology. This is accomplished by the following equation: fractional difference= (aged value/young value)21. (B)
the fractional difference between young and aged samples at 15 selected loci as measured by array in the 17 donor samples as well as in the
independent cohort (19 samples from individuals .=45 years of age and 47 samples from individuals ,25 years of age taken from the general
population). On average the fractional difference identified in the independent cohort (as measured by sequencing) was approximately 2.2 times
greater in magnitude than was identified in the 17 donors.
doi:10.1371/journal.pgen.1004458.g004
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alterations we identified. First, we identified regions whose
methylation at an age ,45 was strongly hypomethylated, and
the methylation profile in individuals .45 years of age is virtually
the same, though it is more strongly hypomethylated. In these
cases the change is still strikingly significant, but the magnitude of
fraction DNA methylation change is minimal. Second, we see a
single population in samples collected at ,45 years of age that is
shifted toward more hypomethylation in samples collected at .45
years of age. Last, we identified a bimodal distribution in samples
collected ,45 years of age that, in samples .45 years of age,
is stabilized into a single population (Figure 5). This could be
indicative of at least two sperm subpopulations, which are biased
to a single, more hypomethylated sperm population with age. In
every case the results suggest that all of the alterations we detected
with the array are the result of the entire sperm population being
altered in similar subtle ways and not a result of a dramatic
alteration in a small portion of the sperm population.
GO term, Pathway and disease association analysis
The genes affected by the age associated methylation alterations
(those that have alterations that occur at their promoter, or gene
body) were analyzed by Pathway, GO and disease association
analysis. The results indicate that no one GO term or Pathway is
significantly altered in our gene group. Similarly, there were no
significant diseases or disease classes associated with the genes
identified in this study based on results of the disease association
tool on DAVID. However the most significant disease hits (those
that were significant prior to multiple comparison correction) have
both been suggested to have increased incidence in the offspring of
older fathers, namely myotonic dystrophy and schizophrenia [2,7].
To directly investigate the disease association(s) in our set of
genes we searched the National Institute of Health’s (NIH) genetic
association database (GAD). We investigated all 117 genes that
were determined to have age associated methylation alterations
(110 hypomethylated; 7 hypermethylated) for their various disease
associations. From these a total of 46 genes have been confirmed
to be associated with either a phenotypic alteration or a disease
based on GAD annotation. We identified 4 diseases that were most
commonly associated with our set of genes (those disease that are
associated with at least 2 genes identified in our study; diabetes
mellitus, hypertension, bipolar disorder and schizophrenia). To
further investigate these associations, we analyzed the frequency
of genes associated with these 4 diseases in our gene set and
compared it to their frequency in all 11,306 genes known to be
associated with either a phenotypic alteration or a disease. Only
bipolar disorder appeared to be more frequently associated with
our identified genes than the background set of genes, based on
chi-squared analysis with multiple comparison correction (Bonfer-
onni) of the 117 age associated genes identified in our analyses
(p = 0.012). Interestingly, schizophrenia also appeared to trend
Figure 5. Single molecule analysis reveled 3 distinct alterations that occur with age. (A) DRD4 has only slight alterations associated with
age because the young cohort (,45) is strongly hypomethylated initially, and aging simply amplifies this. RDMR_2 is representative of many
alterations observed in this analysis which had a strong population shift from moderately hypomethylated to hypomethylated. TBKBP1 is
representative of sites that had a bimodal distribution methylation patterns in the young group that becomes stabilized with age. (B) in every case
(DRD4, RDMR_2, TBKBP1) each region has significant demethylation with age though the magnitude of change varies.
doi:10.1371/journal.pgen.1004458.g005
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toward increased frequency (p = 0.07; figure 6). However, it is
important to note that these are not considered significant
enrichments if considering correction for comparisons with all
genes in the genome (omitting the filter for a disease connection).
The frequency of genetic association between our gene set and the
background gene set was statistically similar for both hypertension
and diabetes mellitus.
Discussion
Herein we report alterations to sperm DNA methylation
associated with age. Interestingly, our data are in contrast with
previous reports of age-associated methylation alterations in
somatic cells. Recent literature suggests age-associated global
hypomethylation with regional (gene associated) hypermethylation
in somatic tissue [20,21]. In contrast, our data reveal age-
associated hypermethylation globally with a strong bias toward
hypomethylation regionally. This is less surprising when we take
into account the fact that sperm are known to have other age-
associated modifications that defy convention (i.e. telomere length)
[26–28]. Intriguingly, while the methylation alterations reported
herein are relatively subtle, they are strikingly significant and are
common among individuals at various ages and intervals between
collections, suggesting that these regions are consistently altered
over time in a linear fashion. Importantly, it appears that many
significantly altered regions are at loci that may contribute to
various diseases known to have increased incidence in the offspring
of older fathers. Coupling these with our data demonstrating that
no one GO term or pathway is up or down-regulated in the sperm,
as a result of the aging process, suggests that the alterations
we observed are the result of regional genomic susceptibility to
methylation alteration and not the activation or inhibition of any
one cellular program. This hypothesis also comports well with the
linear nature of the alterations we observed at most loci. While
the nature of this susceptibility is difficult to elucidate, it may be
related to chromatin architecture.
It should be noted that while we have identified many intriguing
alterations to the sperm methylome, these likely do not represent
all of the consistently altered regions that occur in the sperm over
time. Our approach was to identify alterations with the use of a
‘‘promoter array’’ which has inherent biases. Specifically, the array
is tiled with a higher density of probes at promoter or gene dense
regions. Taken together with the use of a restricted window size
(1000 bps) for searching the genome, this results in a bias toward
identifying regions that are well covered on the array. While this
bias is real, it does not invalidate the regions we have identified,
but it suggests that more regions may be affected that are poorly
covered on the array. Additionally, there are inherent concerns
with the collection of tissues over time. One such concern is the
difference in freezing methods over the years and the role this may
play in methylation profiles. While it is unlikely that this alone
could affect methylation profiles, the variances over time should
still be reported. Our laboratory’s protocol for freezing samples
has been consistent for the times of collection of all samples
included in this study. We have used the same cryomedium,
test yolk buffer, over these years. It is unlikely then, that the
methylation patterns in these samples are affected based on any of
these variables, and thus the perturbations identified herein
represent a true biological change to the sperm epigenome. This
is supported by our replication dataset in which young and aged
samples were collected concurrently.
Localization of altered regions
To investigate the attributes of regions that we determined to be
most susceptible to methylation alterations, we evaluated the co-
localization of significantly altered loci in our study with regions
of nucleosome retention in the mature sperm. It appears that
hypomethylation events are most commonly associated with sites
of nucleosome retention. It should be noted that our criteria for
sites of nucleosome retention is simply that our sites of alteration
occur within 1 kb of known retention sites and thus there may be a
greater degree of complexity in the actual sites of methylation
alteration than we have identified. The actual nature of methy-
lation patterns at a higher resolution in these regions (whether the
affected regions are flanking or directly associated with histones) is
difficult to elucidate due to the nature of array tiling in many of
the loci we identified. Interestingly, this same co-localization was
not seen with hypermethylation events. Though co-localization
patterns are significantly different between the hypomethylation
and hypermethylation events, it should be noted that the sample
size is quite small in the hypermethylation group (8 significant
windows). It should also be noted that while the co-localization
of histones and the hypomethylation events we observed in our
study are significant, the methylation marks observed are likely
established earlier in spermatogenesis and thus may not be affected
by the nucleosome architecture in the fully matured sperm. In
addition, the alterations identified in this study are not localized
everywhere that histones are retained, thus nucleosome retention
alone can’t be the independent driving force of regional suscep-
tibility to methylation alterations. It should be further noted that
our approach was not targeted to observe changes in chromatin
co-localization patterns and as such this represents a secondary
analysis of these patterns with the use of a ‘‘promoter array.’’ As a
result of observing only a selected portion of the genome, there are
Figure 6. The frequency of disease associations within our
gene set was analyzed and compared to the frequency of
disease associations for all genes known to be associated with
at least a single disease based on GAD annotation. Schizophre-
nia, bipolar disorder, diabetes mellitus and hypertension were selected,
as there were at least 3 genes in our small set of identified genes that
are associated with these diseases. Only bipolar disorder was more
frequently associated with our identified genes than the background
set of genes, based on chi-squared analysis with multiple comparison
correction (Bonferonni) of the 117 age associated genes analyzed
(p = 0.012), and schizophrenia also trended toward increased frequency
(p = 0.07). However, these are not considered significant enrichments if
considering all genes in the genome (omitting the filter for a disease
connection). The frequency of genes associated with hypertension and
diabetes mellitus in the two groups was statistically similar.
doi:10.1371/journal.pgen.1004458.g006
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clear biases that are introduced that should be taken into account
when considering these findings.
Recent literature suggests an interesting hypothesis of
‘‘selfish spermatogonial selection’’ that may have application in
this study as well [29]. Briefly, the hypothesis states that some gene
mutations that are causative of abnormalities in the offspring are
beneficial to spermatogenesis and become enriched throughout
the aging process in spermatogonial stem cells. Thus, sperm
carrying these mutations become more frequent in the population
to the detriment of the offspring. Similarly, it is possible that the
age-associated methylation alterations we have identified may be
in regions that are important to spermatogenesis and thus would
be selected for. While the genes identified herein are not well
known spermatogenesis hotspots, they may lie close to other genes
that are important in development and thus may be subject to a
looser chromatin state leaving these genes more susceptible to
methylation perturbations.
The hypomethylation events we identified could occur as a
result of either active or passive demethylation. For example,
regional transcription activity at loci important in spermatogenesis
would likely be accompanied by a relaxed chromatin structure that
could result in increased frequency of DNA damage over time.
Established methylation marks located within this region could
then be passively removed through repair mechanisms in the
developing sperm. If the removal of this mark is either beneficial or
has no effect on spermatogenesis it will persist, and over time
similar marks could accumulate at nearby CpGs ultimately leading
to the profile we identified in our study. It should also be noted
that the accumulation of de novo mutations could lead to a similar
profile. It is clear that the number of mutations in the sperm
increase with age, and if these mutations involve deamination of
cytosine residues the resulting sequence could appear as a loss of
methylation with the technologies utilized herein. However, the
mutation load, and specifically these C to T transitions, in sperm
are stochastic in nature and thus cannot be the primary driving
factor for the genomic hotspots of age-associated hypomethylation
seen in virtually all of the individuals screened [30]. Alternatively,
active enzymatic removal of methylation marks in the sperm
might drive age-associated methylation changes. For this to be
mechanistically plausible we would have to assume that hypo-
methylation in the windows we identified is always beneficial
to spermatogenesis. While either of these mechanisms is plausible,
it is likely that the effects we have identified involve some
combination of both.
The mechanics of hypermethylation events with age are more
difficult to elucidate, as this, by definition, has to be an active
targeted process involving methyltransferase enzymes. However,
some evidence from this study indicates DNA sequence may be an
important driver of age-related hypermethylation. Of the 7
windows that we identified with gene-associated hypermethylation
with age, 4 are associated with the FAM86 family of genes that
are categorized not by protein function or genomic location but
sequence similarity. This strongly suggests that, at least in part, age
associated hypermethylation events at specific loci are driven,
either directly or indirectly, by DNA sequence. Interestingly, this
family of genes (FAM86) with unknown function has recently been
categorized with a larger family of methyltransferase genes, though
it remains unclear what the FAM86 target(s) is/are (DNA,
Histone, other proteins, etc.). It is important to note that in
addition to these regional hypermethyaltion events, globally DNA
methylation is markedly increased as well. The possible role of
chromatin modifications (histone tail modifications, etc) in this
process is also important to note, as what we have identified
may be linked to regional histone methylation, acetylation, etc.
Such histone modifications may reflect underlying transcriptional
changes during spermatogenesis. Taken together, the mechanisms
that drive age-related methylation alterations in the sperm remain
elusive, but likely involve both active and passive methylation
modification.
Biological significance
It is important to consider two questions in determining the
biological impacts of the identified methylation changes in this
study. First, are the methylation changes described herein capable
of transcriptional alterations? Second, are these methylation
changes capable of avoiding embryonic methylation reprogram-
ming? Regardless of the mechanism by which these methylation
marks are altered in the sperm over time, it is striking that these
changes occur with such consistency between individuals and have
such a tight association with age that was seen in both the paired
donor analysis and the independent cohort analysis. This is in stark
contrast to the relative stability of the sperm methylome seen
over time within each individual in the majority of the genome.
One limitation of these findings, however, is the magnitude of
alterations we have discovered. As described earlier the average
fraction methylation alteration per year was approximately a
change of 0.281%. Though this seems relatively small, when
expanded to include the possible reasonable reproductive years in
a male the change would be 10–12%. The increased magnitude
of change with increasing age is strongly supported by our
independent cohort study where an increase in the age difference
between two groups was directly correlated with an increase in the
magnitude of methylation alterations at virtually every locus
screened in a relatively linear manner. Importantly, based on our
analysis of complete nucleotide sequences from our sequencing
data it appears that this decrease of 10–12% reflects changes to
random CpGs within windows of susceptibility in all sperm, which
would manifest in an individual sperm as a mosaically methylated
region. The resultant 10–12% change in methylation within
every individual sperm (effectively 1 out of every 10 CpGs are
demethylated) suggests that every sperm carries similar, more
subtle, alterations within these regions on average.
It is important to note that because we only investigated a
portion of the regions of interest in our sequencing run (used for
confirmation of array results) and the amplicons we probed made
up only a portion of the regions of interest, we can not make a
definitive overarching statement about the dynamics of methyla-
tion profile population shifts in sperm as a result of age. Despite
this, the consistency of population shifts in the regions we were able
to observe suggests that other regions of interest would likely follow
similar patterns. Regardless, the resultant age-associated epigenet-
ic landscape alterations may contribute to disease susceptibility in
the offspring despite the small degree of change though the
increased risk to the offspring may be relatively small. Figure 7
illustrates the alterations seen at two representative loci from our
analysis, Dopamine receptor D4 (DRD4; ENSG00000170956)
and tenascin XB (TNXB; ENSG00000168477).
The heritability of such marks is more difficult to elucidate
mainly because the current study does not directly address this
question. However, this issue needs to be addressed as the
identified age-associated methylation alterations in the mature
sperm may be removed through the embryonic demethylation
wave. Despite the fact that there is no direct evidence of
methylation alteration heritability at the specific loci presented
in this work, the observed age-associated changes at regions known
to be of significance in diseases with increased incidence in the
offspring of aged males is striking and warrants further study.
The intriguing localization of these alterations suggests that the
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methylation profile in the mature sperm, at specific loci, either
contributes to the increased incidence of associated abnormalities
in the offspring or that they reflect (are downstream of) changes
that are actually causative of the associated abnormalities in
the offspring. Moreover, it has been previously proposed that
epigenetic alterations are among the most likely candidates to
transmit such transgenerational effects, and we have identified
methylation alterations that appear capable of contributing to the
various pathologies associated with advanced paternal age. Despite
this, future work must still be performed to determine the real
impact these marks have on transcription and thus phenotype
and disease. Taken together, these subtle yet highly significant,
age-associated alterations to the sperm methylation profile are
intriguing because of their location and consistency, but more
work is required to elucidate the biological impact of these marks.
There are many genes identified in our study that, if biologically
affected, may result in pathologies in the offspring. DRD4 is one
of the most widely implicated genes in the pathology of both
schizophrenia and bipolar disorder as well as many other
neuropsychiatric disorders [31,32]. Interestingly, the entire
DRD4 gene itself is hypomethylated with age (Figure 7). TNXB
has also been suggested to be associated with schizophrenia based
on multiple studies, though the data are controversial [33,34], and
virtually the entire 1st exon of TNXB is hypomethylated with age.
Additionally, DMPK (ENSG00000104936), a gene identified in
our study, is known to be associated with myotonic dystrophy, a
disease for which advanced paternal age is a risk factor [7]. In fact,
increases in trinucleotide repeats in DMPK are believed to be the
cause of myotonic dystrophy type 1. Importantly, previous data
suggests that altered methylation marks may affect trinucleotide
instability [35]. These examples represent only a portion of the
genes that were identified in our study and support the hypothesis
that age-associated DNA methylation alterations in sperm may
play a role in the etiology of various diseases associated with
advanced paternal age.
Future directions
There are two important findings in this study. First, that there
are any age-associated alterations common among such a varied
study population (in terms of the age at collection) is remarkable.
Specifically, age-associated methylation alterations occur in the
sperm regardless of whether the ages between collections are
approximately 20 to 30 years of age or 50 to 60 years of age.
Second, the increased frequency of genes associated with bipolar
disorder and schizophrenia in our study when compared to all
genes associated with disease provides intriguing insight into the
increased susceptibility of these specific disorders in the offspring
of older fathers. Though frequently hypothesized, this work
comprises, to the best of our knowledge, the first direct evidence
suggesting the plausibility of epigenetic alterations in the sperm of
aged fathers influencing, or even causing, disease in the offspring.
Because of the nature of the unique sample set we have utilized
in this study future work is needed to directly address a number of
questions. Are methylation alterations, similar to those seen in our
study, causative of neuropsychiatric disease? Can the methylation
marks we observe in our study avoid embryonic demethylation?
Future targeted work is required to directly address these questions
to enable us to determine the role that these altered methylation
marks play in the increased incidence of various diseases seen in
the offspring of older fathers.
Methods
Ethics statement
The Institutional Review Board at the University of Utah
approved this study. Written informed consent was obtained from
all participants for their tissues to be utilized for this work.
Study group
Under an Institutional Review Board approved study our
laboratory has accessed samples from 17 sperm donors (of known
Figure 7. Various descriptive statistics are presented for both TNXB and DRD4; 2 regions of representative methylation alterations.
(A,B) The alignment track for each gene is displayed in Integrated Genome Browser (IGB) with the associated false discovery rate (FDR) denoting the
significance of the change and the absolute log 2 ratio reflecting the magnitude of the alteration. (C,D) Scatter plots for each sample from all 17
donors (a total of 34 samples with each donor represented twice) with linear regression lines and associated r2 values were generated. Regression
analysis revealed a significant decrease in methylation with age at both DRD4 and TNXB (p = 0.0005 and p= 0.003 respectively). (E,F) The average
methylation within each window (DRD4 and TNXB) was plotted for each paired sample set and is displayed for each donor.
doi:10.1371/journal.pgen.1004458.g007
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fertility) that were collected in the 1990’s. These donors provided
an additional semen sample in 2008, enabling the evaluation of
intra-individual changes to sperm DNA methylation with age.
These samples are referred to as young (1990’s collection) and
aged (2008 collection) samples. The age difference between each
collection varied between 9 and 19 years, and the age at first
collection (‘‘young’’ sample) was between 23 and 56 years of age.
At every collection donors were required to strictly follow the
University of Utah Andrology Laboratory collection instructions,
which includes abstinence time of between 2 and 5 days.
The whole ejaculate (no sperm selection method was employed)
collected at each visit was frozen in a 1:1 ratio with Test Yolk
Buffer (TYB; Irvine Scientific, Irvine, CA) and stored in liquid
nitrogen prior to DNA isolation. Samples were thawed and the
DNA was extracted simultaneously to decrease batch effects.
Sperm DNA was extracted with the use of a sperm-specific
extraction protocol used routinely in our laboratory [36]. Briefly,
sperm DNA was isolated by enzymatic and detergent-based lysis
followed by treatment with RNase and finally DNA precipitation
using isopropanol and salt, with subsequent DNA cleanup using
ethanol. To ensure the absence of potential contamination from
somatic cells the samples were visually inspected prior to DNA
extraction. Additionally, we analyzed our sequencing results in an
attempt to identify reads that did not match the methylation
profile of sperm but instead reflected that of leukocytes. We also
analyzed imprinted regions from our array data in an attempt to
identify fraction methylation values that were inconsistent with
previous reports of sperm DNA methylation patterns. Specifically,
at a region of the IGF-2 locus that is tiled on the 450K array, it has
been previously shown that sperm DNA is strongly hypermeth-
lyated with a fraction methylation of approximately 0.8–0.85 and
in leukocytes this same region is strongly demethylated with a
fraction methylation of,0.1 [37]. Our array data indicate average
methylation in every sample screened at these sites is approx-
imately 0.844. In summary, with neither approach did we identify
any signal that indicated leukocyte or other somatic cell
contamination.
Pyrosequencing analysis
Each sample was subjected to pyrosequencing analysis of a
portion of the LINE-1 repetitive element for the purpose of
confirming previously determined global methylation changes with
age. Briefly, isolated sperm DNA samples were submitted to
EpigenDx (Hopkinton, MA) for pyrosequencing analysis. Qiagen’s
PyroMark LINE1 kit was used to determine methylation status at
each CpG investigated with the assay. The experiment was
performed based on manufacturer recommendations. The resul-
tant values for each CpG are reported as fraction methylation, or
the percent of methylated cytosines at that specifc CpG position.
The average of these values was calculated for each individual
(young and aged), and the values were compared both by linear
regression and by a paired t-test.
Microarray analysis
Each of the paired samples for the 17 donors (a total of 34
samples) was subjected to array analysis using the Infinium
HumanMethylation 450 Bead Chip micro-array (Illumina, San
Diego CA). Extracted sperm DNA was bisulfite converted with
EZ-96 DNA Methylation-Gold kit (Zymo Research, Irvine CA)
according to manufacturer’s recommendations. Converted DNA
was then hybridized to the array and analyzed according to
Illumina protocols at the University of Utah genomics core facility.
Once scanned and analyzed for methylation levels at each CpG a
b-value was generated by applying the average methylated and
unmethylated intensities at each CpG using the calculation:
b-value =methylated/(methylated+unmethylated). The resultant
b-value ranges from 0 to 1 and indicates the relative levels of
methylation at each CpG with highly methylated sites scoring
close to 1 and unmethylated sites scoring close to 0.
The raw data were subjected to normalization to ensure the
removal of poorly performing probes from the downstream
analysis (probes with a QC p,0.05). Batch effect correction
and basic descriptive analyses of the microarray data were
performed using Partek (St. Louis MO). More in depth analysis
was performed using the USeq platform with the application
Methylation Array Scanner which identifies regions of altered
methylation that are common among individuals utilizing a sliding
window analysis. Briefly, paired data from each donor (young and
aged) was subjected to a 1000 base pair sliding window analysis
where regions of altered methylation with age that are common
among donors were called by Wilcoxon Signed Rank Test. To
diminish the influence of outliers in the data set, methylation for a
specific window was reported as a pseudo-median and differences
between the young and aged sample are reported as log 2 ratios.
Two thresholds were applied to identify windows with significant
differential methylation. A Benjamini Hochberg corrected Wil-
coxon Signed Rank Test FDR of ,=0.0001 (.= transformed
FDR of 40) and an absolute log2 ratio .=0.2 was used as our
threshold for significance. Raw FDR values were transformed
for visualization in figures and reference in this text ((210 log10
(q-value FDR)), such that a transformed FDR value of 13= 0.05,
20= 0.01, 25= 0.003, 30= 0.001, and 40= 0.0001, etc. We
selected this robust level of significance, as opposed to an FDR
of .=13 (corrected p-value of 0.05), to ensure that we selected
only the most striking alterations that are consistently perturbed in
most or all of the individuals screened. To confirm the significance
of each of the called windows we subjected the mean b-value
within the window for each donor (young and aged samples) to a
paired t-test. Following this initial filter we additionally subjected
each significant window to a regression analysis (age at time of
collection versus average methylation within significant windows)
to determine the relationship between age and mean methylation
within each window. Regression analysis and paired t-tests were
performed using STATA 11 software package. A p-value of,0.05
was considered significant for these analyses.
Sequencing analysis
We performed multiplex sequencing in a replication cohort as a
confirmation that the alterations identified in the paired donors
via array represent methylation alterations that are common in
human sperm with age.
First, each donor sample used in the array study was
additionally subjected to targeted bisulfite sequencing at loci
determined to be most consistently altered based on the window
analysis. This step was designed to confirm the array results and to
provide greater depth of coverage of the CpGs in the windows of
interest. Primers for 21 loci were designed using MethPrimer
(Li Lab, UCSF). PCR was performed on samples following sperm
DNA bisulfite conversion with EZ-96 DNA Methylation-Gold kit
(Zymo Research, Irvine CA). PCR products were purified with
QIAquick PCR Purification Kit (Qiagen, Valencia CA) and were
pooled for each sample. The pooled products were delivered to the
Microarray and Genomic Analysis core facility at the University of
Utah for library prep which included shearing of the DNA with a
Covaris sonicator to generate products of approximately 300 base
pairs, in preparation for 150 bp paired end sequencing, and the
addition of sample-specific barcodes for all 34 samples. Multiplex
Sperm DNA Methylation and Aging
PLOS Genetics | www.plosgenetics.org 11 July 2014 | Volume 10 | Issue 7 | e1004458
37
sequencing was then performed on a single lane on the MiSeq
platform (Illumina, San Diego CA).
Second, 19 sperm DNA samples from an independent,
unselected cohort of general population donors who were $45
of ages were selected and compared to 47 sperm DNA samples
from general population donors who were,25 years of age. These
samples underwent the same preparation as described above for
multiplex sequencing, though only 15 amplicons were targeted in
this study of larger sample size. Average fraction methylation for
each window was determined and was subjected to unpaired t tests
between the young and aged groups.
Single molecule analysis of targeted bisulfite sequencing
data
Bisulfite sequencing data was aligned against the human
reference genome Hg19 using Novoalign. The aligned reads were
processed using Novoalign Bisulfite Parser, BisStat and Parse Point
Data Context for CG from the USeq package. The binned CpG
graphs were generated using a modified version of the Allelic
Methylation Detector from the USeq package. In short, all reads
were queried for their number of CpGs. A consensus CpG number
was then taken based on the highest number of CpGs per read and
a minimum of 10% of all aligned reads (approximately 100 reads
per region) must cover said number of CpGs. The consensus CpG
number then served as the basis for the number of bins per region.
Samples that were donated at an age of 45 years or older were
coalesced in silico in the ‘‘aged donor group’’. Conversely, samples
younger than 45 years were grouped in the ‘‘young donor group’’.
All reads for the consensus CpG count were summed up based on
their age group and then normalized to a 100 reads total. The
graphs plotting normalized reads to methylation bins were then
generated using the spline function from the R package.
GO term/Pathway/disease association analysis
GO term Analysis was performed with Gene Ontology
Enrichment Analysis and Visualization Tool (GOrilla; cbl-gorilla.
cs.technion.ac.il). Pathway and disease association analysis was
performed on the Database of Annotation, Visualization, and
Integrated Discovery (DAVID; david.abcc.ncifcrf.gov) v6.7. Addi-
tional disease association analysis was performed directly on the
National Institute of Health’s Genetic Association Database (GAD;
geneticassociationdb.nih.gov).
Additional statistical analyses
Fishers exact test was used to determine the differences in
frequencies of genes associated with particular diseases between
our significant gene group and a background group. This analysis
was also used to detect the differences in frequencies of windows
that were found in regions of histone retention in the hypomethy-
lation group and the hypermethylation group. Additionally,
regression analysis was utilized to determine relationships between
age and methylation status at various loci. STATA software
package was used to test for significance with a p,0.05 being
considered a significant finding.
Supporting Information
Table S1 Genomic features of significantly altered windows.
Represented in this table are the windows of significance that were
identified in our study as well as their transformed FDR, log 2
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3CHAPTER 3
PANDA: A NOVEL TOOL TO INVESTIGATE POLYADENYLATION CHANGES 
FROM NEXT-GENERATION TOTAL RNASEQ DATA
Chapter 3 is a manuscript in preparation for publication. The authors of this 
manuscript are Christian Pﬂ üger, David Nix and Bradley Cairns. 
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3.1  Abstract
PolyA changes are physiological adaptions to RNAs in cells in order to 
control RNA stability and translational efﬁ ciency in maturing oocytes. It is of great 
interest to the scientiﬁ c community to study transcript wide polyA changes in 
various developmental contexts and disease models. Recently, a polyA sequencing 
approach was shown to determine polyA tail lengths for a complete transcriptome. 
However, this sequencing technique is very specialized and requires total RNA 
amounts of 1-50 ug. Here we detail a bioinformatics approach, coined PANDA, 
that can detect relative polyA changes between transcripts using data from total 
RNAseq performed on samples with as low as 5 ng input RNA. PANDA enables the 
user to detect polyA changes from total RNAseq data that are not polyA selected. 
We identiﬁ ed that the frequency of adenine homopolymers with a length of >= 7 at 
the end of sequences in RNAseq datasets is signiﬁ cantly higher statistically than 
corresponding distribution of adenine homopolymers observed in either the human 
or mouse genome. This method also shows that changes in the ratio of reads over 
an exon that contain polyA to reads lacking polyA (polyA ratio) strongly correlate 
with changes in polyA length over the same exon. PANDA allows for PolyA detection 
based on a variable PolyA seed length where a shorter seed length comes at the 
expense of increased computational time. We recommend triplicates per condition 
sequenced at a minimum depth of 20 million reads. PANDA has the potential to 
identify transcriptome wide polyA changes for any RNAseq dataset that is not 
biased for polyA, which could be of particular interest to the ﬁ eld of neurobiology 
and cancer research where the cells are known to alter their polyA usage.   
3.2  Introduction
A hallmark of cellular activity is the transcription of genomic information into 
RNA, essentially creating copies of the master DNA repository and using these 
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RNA transcripts for a variety of cellular functions 1. Importantly, the stability and 
hence the half life of these copies need to be tightly regulated in order to ensure 
turn over and allow for adaptations to a changing environment 2,3. The regulation 
of RNA stability and, in case of mRNA, the translation of such into protein, is 
considered a posttranscriptional process. A key posttranscriptional change at RNAs 
involves a process known as polyadenylation (polyA) that extends about 50-300 
adenine nucleotides at the 3’ prime end of the transcript. PolyA changes at mRNAs 
have been implicated to stabilize transcripts4,5 as well as promote translational 
efﬁ ciency6,7. It has been shown that the default mode for RNA biogenesis is the co-
transcriptionally polyadenylation in the nucleus8. However, a notable exception in 
development of maturing oocytes is the mechanism of cytosolic polyadenylation9-12. 
Brieﬂ y, transcripts that are used for late stage oogenesis or in the early developing 
embryo, a period in time where the genome is transcriptionally inactive and no 
new RNA transcripts are generated, are shown to skip nuclear polyadenylation 
and instead gain polyA in the cytosol. The regulatory element involved in mediating 
cytosolic polyadenylation, CPE (cytosolic polyadenylation element), has been 
shown to be part of the primary RNA sequence13-15. Further, binding proteins 
called CPEBs (cytosolic polyadenylation element binding protein) can recognize 
the CPE allowing for accurate timing of cytosolic polyadenylation upon their 
phosphorylation10,13,14,16,17.  Most notably, the physiological process of cytosolic polyA 
gain has an essential role during the maturation of oocytes and in early embryos, 
before embryonic genome activation (EGA). EGA is the key point in embryonic 
development, when the genome in the embryo becomes transcriptionally active, 
producing newly synthesized RNAs with new polyA tails. At these developmental 
stages, cytosolic polyA has been extensively studied in Xenopous and Drosohilla 
oocytes and early embryos 9,12,14,15,18-22. However, transcript wide analysis of polyA 
changes has only recently been described using PALseq23 that requires a fair 
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amount of RNA input (>1ug) as well as a specialized sequencing setup. Here we 
describe PANDA (Polyadenylation from Next Generation Total RNAseq Differential 
Analysis), which can be used to analyze polyA changes between two different 
conditions. One signicant of this analysis method is that it uses standardized 
sequencing and library preparation methods. PANDA is part of the USeq package 
(http://useq.sourceforge.net)24 and is also written in Java for platform independent 
usage. 
Here we ask the question of whether polyA changes can be studied from 
total RNAseq data and we present a novel bioinformatics approach of investigating 
this biologically relevant question.
3.3  Results
PANDA as part of the USeq package was used to process two different 
datasets. We chose to analyze previously published data from tumor-associated 
macrophages (TAMs)25  to serve as a negative control for PANDA since the miRNA 
manipulations used in that dataset was thought to not result in polyA level changes. 
The second dataset we used was total RNAseq from human oocytes from our 
lab which was expected to change polyA during the oocyte maturation phase. 
The choice for these two datasets was based on two criteria. Firstly, the datasets 
needed to be derived from total RNA where the library preparation method did not 
involve biasing for the polyadenylation status. This was achieved by either ribozero 
treatment to remove ribosomal RNA from the input into the library preparation 
followed by random hexamer reverse transcription for the TAMs dataset. Similarly, 
the human oocytes total RNA library was prepared using the Totalscript™ kit 
(Epicentre) that uses tagmenation with the Tn5 transposases in conjuction with 
proprietary buffer conditions to reduce ribosomal RNAs. Notably, neither library 
preparation uses oligodT and hence lacks a bias for the polyA status on the 3-prime 
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end of the RNAs. Secondly, every sample sequenced in these two datasets was 
sequenced with either 50bp paired-end or 101bp paired-end sequencing. The 
advantage of using paired-end sequencing data is to increase the dynamic range of 
reads that can be uniquely attributed as polyA. For example, reads that have more 
than 80% polyA present in their sequence can only be mapped uniquely by their 
read pair. Hence, paired-end sequencing data allows in some cases to attribute 
a polyA feature based on the mate’s read. The choice of datasets analyzed was 
based on two aspects. The human oocyte dataset revealed signiﬁ cant changes in 
polyA levels during oocytes maturation. On the contrary, as expected, the TAMs 
dataset did not exhibit any substantial amount of transcripts with polyA changes. 
3.3.1  PolyA Frequency in RNAseq Datasets is Statistically Signiﬁ cant Higher     
than in Human or Mouse Genomes
To justify the development of PANDA, we wanted to determine the dynamic 
range allowing us to detect polyA differences in total RNAseq data compared 
to adenine-homopolymer occurrence in the reference genome. We deﬁ ned the 
dynamic range as the difference between polyA length occurrence in the genome 
and in a total RNAseq dataset. To test this, we analyzed the occurrence of 
adenine-homopolymer stretches in the human and the mouse reference genome 
as detailed in Figure 3.1A. As seen in the frequency plot, the separation of polyA 
length frequency starts at 7 nt and only increases all the way up to 62 nt. Also, 
neither genome has any adenine-homopolymers longer than 62 nt. In contrast to 
the genomic adenine-homopolymers, the frequency of polyA stretches in the TAMs 
dataset reveals a higher occurrence already at 7 or more adenine-homopolymers 
with a frequency of 7.6% and 7.4% for the human and mouse genome, respectively, 
and 16.8% for the TAMs dataset. Notably, the difference in distribution is highly 
statistically signiﬁ cant (p<0.0001). Comparing the occurrence of adenine-
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homopolymers from human oocytes to the genomes (Figure 3.1B) also reveals 
a highly statistically different frequency distribution (p<0.0001). Remarkably, the 
unﬁ ltered data from GV to MI oocytes exhibits a statistically signiﬁ cant difference 
in polyA frequency distribution. Further, there is a spike visible at the 101 nt mark 
indicating the presence of 101 adenine-homopolymers in the raw sequencing ﬁ le. 
These 101 adenine-homopolymers could later be mapped if a read pair exists with 
a sufﬁ ciently mappable sequence.
3.3.2  The PANDA Workﬂ ow in Detail
Figure 3.2 illustrates the overall workﬂ ow of PANDA. The ﬁ rst step involves 
parsing the raw sequencing ﬁ les (FASTQs) using the FastQPolyAParser program. 
As shown in the top part of Figure 3.2, raw reads are ﬁ ltered for sequences that 
contain a adenine-homopolymer stretch at the 3’ end or a thymine-homopolymer 
stretch at the 5’ end. The FastqQPolyAParser has an option for the user to select 
the seed length (minimum adenine homopolymer count) with the default set to 6 
or more ‘A’s. This results in all sequences that adhere to that criteria being saved 
in a separate FASTQ ﬁ le. The original read in the FASTQ ﬁ le that will undergo 
alignment is trimmed back to remove all adenine homopolymers at the 3’ end or 
thymine homopolymers at the 5’ end, respectively, as well as the corresponding 
sequence quality values. Importantly, if the program encounters 101 adenines or 
101 thymines, the trimming process will leave a single A or T in order to not produce 
a read without any sequence information. Notably, the seed length parameter 
inﬂ uences the identiﬁ cation of reads containing polyA albeit at a heavy cost in 
computational time. Figure 3.3 illustrates that while there is a gain of about 15% in 
polyA reads when the seed length is reduced from 6 to 5, the computational cost 
increases exponentially to 5-fold. Importantly, the computational time required for 
checking reads against the genomic adenine-homopolymer database is largely 
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dependent on disk I/O (input/output; hard drive or solid state drive speed). Hence, 
a good compromise for polyA reads identiﬁ ed and CPU time usage is the parameter 
‘6’ for the polyA seed length. 
The next step involves the alignment of the trimmed FASTQ ﬁ les. We 
used Novoalign to obtain reads mapped back in genome coordinate space. 
Subsequently, the SAM alignment ﬁ les are subjected to SamTranscriptomeParser, 
which is also part of the USeq package24. This process ensures the conversion 
of spliced transcript information into genomic coordinates as well as sequence 
and alignment quality scores can be used to ﬁ lter out low quality sequence reads. 
The next step of the PANDAworkﬂ ow, named SAMpolyATFilter, ties together 
the saved PolyA reads from step 1 as well as the BAM alignments from the 
SamTranscriptomeParser output. In essence, SAMpolyATFilter checks every 
alignment for the presence of a longer polyA containing read in the FASTQ ﬁ le that 
contained the saved, untrimmed reads. If the alignment has a match for potential 
polyA, then it is checked against coordinates of genomic adenine-homopolymer 
stretches. Notably, the program checks both the primary read coordinates as well 
as the mate pair coordinates, provided they exist. In case the read matches the 
genomic adenine-homopolymer database, the program just moves on to the next 
read. Conversely, if the read passed the aforementioned genomic ‘A’ check, it is 
considered to be posttranscriptionally modiﬁ ed and hence the length of that polyA 
stretch is determined and saved to the SAM/BAM ﬁ le as a user-deﬁ ned tag. For 
example, if an alignment contained polyA of 25nt length, the SAM alignment is 
then updated with the tag At:i:25, where ‘At’ stands for the user deﬁ ned tag, ‘i’ 
deﬁ nes the value as an integer and the last number indicates the length of the 
polyA nucleotide stretch. Finally, SAMpolyATFilter produces two BAM ﬁ les for each 
input, one for all the reads with the At:i  tag set as well as a BAM ﬁ le that only 
contains reads that have had the At:i  tag set. The latter bam ﬁ le can then be used 
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to visually inspect polyA reads in the genome browser. It is important to note that 
in order to produce bigwig or useq ﬁ les, the normalization needs to be changed 
to total reads passing alignment and sequencing thresholds. As shown in Figure 
3.4A and 3.4B, polyA containing reads are predominantly visible at the 3’ end. An 
example for general polyA in TAMs is shown in Figure 3.4A and 3.4B, detailing the 
total read coverage in charcoal and the polyA read coverage in orange for ActinB 
and Tubulin4b. In contrast, Figure 3.4C depicts altering polyA levels in maturing 
human oocytes (GV, MI and MII) for the DLST gene.
The ﬁ nal step in the PANDA workﬂ ow involves the quantiﬁ cation polyA 
differences from two different conditions. The program named PolyADifferentialSeq 
is accepting two conditions with at least two replicates each, a UCSC gene table 
ﬁ le for exon information. The user has the option to select if the last exon, all exons 
or exons and introns should be quantiﬁ ed.  After running PolyADifferentialSeq, the 
output is a tab-delimited ﬁ le that can easily be loaded up into any spreadsheet 
program for further analysis or ﬁ ltering. The quantiﬁ cation is based on relative 
polyA counts over a given region (e.g. last exon) between two conditions. The log2 
ratio is calculated and a p-Value using a chi-squared test is generated followed 
by multiple test correction using the Benjamini-Hochberg method. The -10*log10 
transformed FDR is then reported. Further, stats like polyA length difference, polyA 
ratio difference as well as all the raw values can be all printed out into the tab-
delimited ﬁ le using the verbose option ‘-v’.  In order to control for the minimum 
number of polyA counts present in both conditions and their combined replicates, 
the ‘-n’ option allows the user set their own threshold, while the default is set to 30. 
Similarly, the ‘-e’ option controls the total read counts of either of the conditions and 
their respective combined replicates. 
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3.3.3  PolyA Ratio and PolyA Length are Correlated
PANDA uses the simple measure of polyA ratio to determine changes in 
polyA levels between two different conditions. The PolyA ratio is determined by 
counting both the polyA reads as well as the total reads over a deﬁ ned region 
(e.g. exon) and simply generating the quotient of both metrics. The fold polyA ratio 
change is further calculated by the log2 ratio of polyA ratio from condition one versus 
condition two. When looking into a quantiﬁ cation method to reproducibly detect 
polyA changes using existing RNAseq data, we noticed that polyA length changes 
correlated very well with polyA ratio changes (see Figure 3.5) with a Pearson’s 
correlation coefﬁ cient of r = 0.794 (p < 0.0001). Remarkably, when the polyA Length 
reduced, the log2 polyA ratio followed the same trend. This observation allowed for 
rapid quantiﬁ cation of polyA counts over a given region.
3.3.4  Sequencing Depth Required for PolyA Analysis
A critical question is the dependency of sequencing depth in order to 
identify differential polyA. As shown in the coefﬁ cient of variation plot for the 45-
55% most polyA reads in Figure 3.6, we started out with 4*107 reads per replicate. 
In order to assess lower read coverage, we performed subsampling four times for 
each replicate using SAMtools26. We covered a broad spectrum cutting down the 
sequencing depth to 2*107, 4*106, 2*106, 4*105 and 4*104 reads, respectively. As 
seen in the graph in Figure 3.6, 2*107 reads per replicate still produces acceptable 
variation values. However, in order to capture even less highly expressed 
transcripts, deeper sequencing will always yield more information about the polyA 
status of each individual transcript. 
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3.4  Discussion
PANDA is a novel tool to investigate polyA changes in a transcriptome that 
has not been oligodT selected. Here we demonstrated a workﬂ ow for using library 
preparation for RNA-seq in combination with the PANDA software to analyze 
changes in polyA. Previously, Subtelny et al. published a remarkable method to 
detect and measure polyA tail length on a transcriptome wide level. However, 
a fundamental limitation of this technique is the total RNA amount necessary to 
investigate polyA length changes (1-50 µg total RNA). Tissue or cells that are 
difﬁ cult to obtain in high enough quantities such as oocytes will pose as a hurdle to 
investigate with the help of PAL-seq. In contrast, PANDA allows for polyA analysis 
with total RNA amounts as low as 5 ng. An important consideration, however, is the 
fact that PAL-seq enables the exact measurement of polyA tail lengths. This enables 
comparison and analysis of polyA tail lengths between different transcripts. PANDA 
in comparison is working with the parameter of relative polyA tail length change 
between two conditions for each individual transcript. The biologically important 
feature of relative polyA change per transcript is also very critical to understand. It 
enables the investigator to ask the question of whether polyA is added or removed 
for select transcripts present in the RNAseq data. While PANDA cannot determine 
the transcriptome wide exact polyA tail length as detailed previously in the PAL-
seq method23, PANDA allows detection of relative polyA changes between two 
conditions. Notably, the total input RNA amount necessary can be as low as 5 ng 
as opposed to 1-50 µg used for PAL-seq. This roughly 1000-fold difference in input 
RNA amounts is absolutely critical when working with hard to obtain tissues like 
oocytes. 
The current maximum polyA length detectable by PANDA is based on 
sequencing read lengths. Illumina version 3 chemistry is currently limited to 101 
nucleotides, which also limits the homopolymeric adenine detection to the same 
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length. It is noteworthy at this point that Illumina version 4 chemistry is now available, 
allowing an 25% increase in read lengths to 125 nts with 125 bp paired-end 
sequencing. This increase in sequencing length will enable an increase in dynamic 
range, increasing the accuracy of calling polyA differences. In the near future, it is 
imaginable that longer read lengths may allow detection of full-length polyA tails. 
An interesting experiment could entail the enrichment of mRNAs followed by 300 
bp paired-end MiSeq sequencing. The theoretical maximum sequencing length of 
600 nt is in a range that could be sufﬁ cient to measure the full spectrum of polyA 
lengths.
In Figure 3.1, we compared the background adenine homopolymer frequency 
to the polyA frequency of transcripts sequenced in either human oocytes or TAMs. 
An interesting observation is the similarity of the human and mouse adenine 
homopolymer frequency. Not surprisingly, the maximum adenine homopolymer 
length is around 60 nt for both genomes. A possible caveat, however, might be 
the assembly of repetitive regions for both genomes, which could possibly harbor 
more and longer adenine homopolymer stretches. Most importantly though, even if 
future genome versions will have better annotations of repetitive regions, PANDA’s 
ability to uniquely call polyA for a transcript will not be changed by that fact. As 
shown in this publication, the possibility of differential polyA analysis with the 
current genome annotation and sequencing technology is very much possible. 
This is also strongly supported by the higher frequency of 7 or more adenines 
at the 3’ end of transcripts compared to the occurrence of 7 or more adenines in 
a homopolymer in the genome. Consequently, it is more likely for PANDA to call 
a read with 7 or more adenines at the 3’ end of a read a true polyA as opposed 
to a genomic adenine homopolymer. Importantly, with an increase in adenine 
homopolymer lengths, the chance for true polyA only increases compared to the 
genome background. Further, the ability of PANDA to call up to 101 nt of polyA, 
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or longer if a longer better sequencing technology is used, illustrates the dynamic 
range currently available. 
In summary, we have developed PANDA to investigate polyA changes in 
RNAseq data that are not polyA selected. PANDA is compatible with previously 
published RNAseq data and can be used in the future for total RNAseq datasets. 
This will open up opportunities to simultaneously investigate transcript changes as 
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Figure 3.1 Comparison of genomic adenine homopolymer frequency to polyA
length in sequenced samples. A) Tumor associated macrophages (TAMs)
polyA length compared to mouse genomic adenine homopolymer frequency.
Statistical test was performed using the Wilcoxon matched-pairs signed rank
test (p<0.0001). B) Human oocytes polyA length compared to human
genomic adenine homopolymer frequency. Statistical test was performed


























































































































































































































































































































































































































































































































Figure 3.3 PolyA detection and computation rate. PolyA detection is dependent 
on polyA seed length. Shorter polyA seed length increases polyA detection but 
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Figure 3.5 polyA length difference is strongly correlated with log2 polyA ratio 
change. The relative change in polyA length can also be captured by the 
normalized counts of polyA reads over the same region. Spearman correlation 
coefﬁ cient is shown (r= 0.794).
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Figure 3.6 Coefﬁ cient of variation plot based on sequencing depth for the 45-55 
percentile most polyadenylated transcripts.
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4  CHAPTER 4
MAJOR CHANGES IN mRNA POLY-ADENYLATION ACCOMPANY 
OOGENESIS AND EARLY EMBRYO DEVELOPMENT                                                              
IN HUMANS
Chapter 4 is a section part of a larger manuscript in preparation for publication. 
The authors of this manuscript are Pete Hendrickson, Jessie Dorais, Christian 
Pﬂ üger, David Nix, Douglas Carrell and Bradley Cairns. This entire section is my 
contribution to the paper.
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4.1  Introduction
In female mammals such as humans, meiosis can halt at prophase I, 
creating germinal vesicles with low transcriptionally activity.  However, entry 
into the M1 phase is accompanied by transcriptional silencing, which has two 
important consequences: Firstly, all RNA transcripts that are required for germ 
cell speciﬁ cation and for processes that drive early pretranscriptional zygotic 
development must be inherited directly; and secondly, any regulation of inherited 
RNA transcripts must involve posttranscriptional mechanisms. A marquee feature 
of transcript stability and translational control in early development is differential 
poly-Adenylation (poly(A)). Recently, poly(A) dynamics were shown to play a 
signiﬁ cant role during early zebraﬁ sh development1. Further, studies in xenopus2 
and drosophila3 have shown that key players such as cyclin B1, Aurora A kinase 
and Mos4 are critical for the ﬁ nal steps in oocyte maturation as well as priming 
the cytoplasm with proteins critical in early embryo development. Hence, post-
transcriptional regulation of mRNAs using differential polyA in late stage oocytes 
is paramount. However, very little is known about the polyA dynamics during early 
development in either mouse or human.
4.2  Methods
To address this issue, our lab obtained RNA extracted from late-stage 
human oocytes as well as early human embryos, obtained from IRB-consented 
couples. We performed total RNAseq analysis using the TotalScript (epicentre) 
library preparation that allows for random hexamer priming of the reverse transcript 
reaction under conditions of small amounts of input RNA in the low nanogram range. 
This in turn enabled us to examine mRNA changes as well as differential poly(A) of 
these transcripts. To investigate poly(A) changes within our total RNAseq datasets 
(which were not oligo(dT) selected and hence have no bias for poly(A)), we have 
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developed an innovative software tool set. Brieﬂ y, the software package, PANDA, 
released as part of the USeq package5, parses raw sequencing reads for possible 
3’ polyA and saves these reads in a separate ﬁ le as well as trims these potentially 
non-genomic polyA nucleotides in silico from that very read. All raw reads including 
the trimmed reads are then subjected to alignment against the reference genome; 
in this case, we used the human genome version 19 (hg19) as reference. Further, 
the aligned reads are then checked against the ﬁ le that contains the original, non-
trimmed reads. If there is a match against the ﬁ le containing the original reads, 
the polyA length (usually between 6-101 bp) is then determined from that original 
read and added to the SAM alignment ﬁ le as a user deﬁ ned tag (At:i:length_of_
polyA, e.g. At:i:62 with a polyA length of 62 nt). Genomic polyA stretches present 
in certain reads are ﬁ ltered out at this point. Remarkably, polyA length can reach 
the maximum sequencing length (in this case up to 101 nt of polyA) provided 
the read’s mate pair can be uniquely aligned. The third and last step involves 
quantiﬁ cation and comparison of polyA levels between two different stages. Brieﬂ y, 
polyA reads are counted over the last exon and normalized by total reads aligned 
over the same exon, yielding the polyA-ratio. Then, the polyA-ratios of two different 
conditions are divided and log2 transformed. Statistics were performed by using 
a chi-square test on polyA counts of two developmental conditions, followed by 
multiple test correction (Benjamini-Hochberg) and negative log10 transformation. 
4.3  Results and Discussion
As shown in Figure 4.1, there are two major waves of increased polyA are 
detectable. Firstly, there is a signiﬁ cant (p<0.0001) increase in polyA length of 
transcripts in the maturing oocyte (MI phase) from an average of ~13.9 nt to ~27.9 
nt that, notably, are then lost or reduced in the mature MII oocyte (~10.9 nt). This 
is thought to allow for translation of proteins critical in maturing the oocyte as well 
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as in the earliest phase of embryo development. Notably, the genome of late stage 
human oocytes and human early embryos until the 4-cell stage is transcriptionally 
inactive. The activation of de novo transcription is thought to start in humans 
between the 4-cell and 8-cell stage, termed embryonic genome activation (EGA)6. 
Secondly, a sharp increase in polyA length (p<0.0001) is detectable right after 
EGA from 10.6 nt polyA to 26.8 nt polyA in cleavage. Clustering analysis (Cluster 
3.0 and Java TreeView) with transcripts that changed polyA dynamics during any 
time in development with an FDR<10e-5 revealed polyA dynamics that correlate 
with oocyte development (Figure 4.2 - cluster 2, p<0.0005). Remarkably, this novel 
polyA analysis picked up previously published key transcripts that were shown to 
be critical for oocyte maturation2,7-10. 
Consequently, the ﬁ rst set of transcripts identiﬁ ed to gain polyA during 
oocyte maturation fall into the category of transcripts that are known to gain polyA 
based on previous work done in drosophila, xenopus and bos taurus2,7-10. Notable 
examples of transcripts involved in cell cycle regulation and critical in obtaining 
cytosolic polyadenylation are CyclinB1 (CCNB1), DAZL, PABPC1L (poly(A) binding 
protein, cytoplasmic 1-like) (Figure 4.2, 4.3, 4.4 and 4.5, respectively), Aurora 
A kinase (AURKA) (Figure 4.6) and Mos (Figure 4.7). As shown in the genome 
snapshots in Figures 4.6 and 4.7 (total reads are depicted in charcoal color and 
reads containing polyA in orange), there are distinct peaks of polyA reads in the 
MI oocyte phase. Remarkably, mature MII oocytes have reduced polyA peaks 
compared to the MI stage. This is possibly due to posttranscriptional regulation 
of mRNA shutting down translation of transcripts by reducing the polyA tail length 
when the appropriate amount of protein is made.  To our knowledge, we are the 
ﬁ rst to show this resolution of polyA dynamics in mammals. 
Further, we were able to identify polyA gain in the MI stage for proteins critical 
for oocyte functions. The majority of these transcripts have not been previously 
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shown to gain cytosolic polyA. However, since these transcripts are known to be 
essential for oocyte maturation and early embryo development, they fall into the 
category of predicted transcripts for cytosolic polyA regulation. Genes that exhibit 
an increase in PolyA during the ﬁ nal stage of maturation include histone H1 oocyte 
variant (H1FOO, Figure 4.8), growth defect factor 9 (GDF9, not shown), the sperm 
receptors zona pelucida 1 and 2 (ZP1/2, shown in Figure 4.9 and Figure 4.10) 
and the endopeptidase responsible for cleaving ZP2 into its physiologically active 
form, and astacin-like metallo-endopeptidase (ASTL, Figure 4.11). A western 
blot analysis of proteins from GV and MII stage showed an increase in cleaved 
ZP2 protein (Figure 4.12), suggesting a functional correlation between polyA 
length gain from GV to MI for ZP2 (ZP2, Figure 4.13) and an increase in ZP2 
protein abundance. Since these genes are well known to be essential for oocyte 
maturation and fertilization, it is not surprising to see these transcripts gain polyA 
at this critical point in oocyte maturation. Importantly, transcripts essential at the 
early zygote stage prior to transcriptome activation, such as DPPA3, (PGC7/Stella, 
developmental pluripotency associated 3 Figure 4.14), involved in protecting 
the maternal genome from active DNA demethylation11, DPPA5 (developmental 
pluripotency associated 5, Figure 4.15)12,13 and OOEP (oocyte expressed protein, 
Figure 4.16), critical in early embryo development14, showed a similar pattern of 
polyA increase at the MI stage similar to AURKA for example. Further, TRIM28 
(Figure 4.17), essential in maintaining imprinting patterns and retro-transposon 
regulation15,16 after EGA, also showed an increase in polyA at the cleavage stage. 
Finally, this novel approach to polyA analysis enabled us to identify 
transcriptions factors, DNA binding proteins and other genes of interest (Table 
4.1) that are notoriously understudied but may have a critical importance in zygote 
development. This set of transcripts are considered novel candidates for cytosolic 
polyA regulation and possibly play an important role in oocyte maturation as well 
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as early embryo development. A noteworthy example is TRIM6 (Figure 4.18), 
which exhibits similar polyA dynamics to c-MOS or ZP2. The intersection of the list 
of transcripts gaining strong polyA from GV to MI with a list of known transcription 
factors and DNA binding proteins (HUGO DNA binding proteins) revealed ZNF770 
(Figure 4.19 and Table 4.1, cluster 5) and SOX13 as potentially interesting and 
important transcription factors for setting up the genome before EGA. Another 
notable candidate in regulating p53 at the late oocyte maturation stage as well 
as zygote stage is PDCD5 (programmed cell death 5, Figure 4.20). As shown in 
the top 25 transcripts by FDR gaining polyA from GV to MI (Figure 4.13), PDCD5 
is present in that list with aforementioned transcripts critical in oocyte and zygote 
development. PCNA (Proliferating Cell Nuclear Antigen, Figure 4.21) is a key 
protein involved in DNA replication17 and it is also signiﬁ cantly polyadenylated 
during the GV to MI transition (Figure 4b). Notably, transcripts gaining polyA from 
GV to MI stage are signiﬁ cantly (p<0.0001) enriched for CPE sites in their 3’UTRs 
vs all known 3’UTRs (Table 4.2)18-21.
In summary, we developed a new method for analyzing polyA dynamics 
in early development that can also be applied to a variety of other datasets or 
cell types that are not oligodT selected. We were able to show an inventory of 
transcripts that receive polyadenylation during the early phase of egg maturation 
(MI) as well as loss of it during the last stage of oocyte maturation (MII). We 
observed a statistically signiﬁ cant enrichment (p<0.05) of transcripts critical for 
oocyte physiology and early embryo development (Figure 4.2, cluster 2 and Table 
4.3). Since it is impossible to functionally test transcripts in human oocytes, we 
implicitly tested this novel polyA analysis by checking hallmark transcripts such as 
CCNB1, AURKA and c-MOS for polyA gain. By conﬁ rming these notable positive 
controls in our polyA analysis, we suggest that other transcripts identiﬁ ed in our 
analysis could also be important targets of cytosolic polyadenylation in human 
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oocytes.  Finally, this polyA analysis suggests the importance of TFs such as Sox13 
and ZNF770 for the start of embryo genome activation (EGA). Future studies will 
need to be performed in order to these factors for their importance during EGA. 
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Figure 4.1 Poly differences during developmental stages. Mean PolyA length 
measured in 4 technical replicates per developmental stage, paired T-test 






































polyA Length per Developmental Stage
*** *** p<0.005***
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Figure 4.2 Clustering of transcripts that change in PolyA with transformed 
FDR > = 40











Figure 4.3 Genome snapshot of PABPC1L gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.4 Genome snapshot of DAZL gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.5 Genome snapshot of CCNB1 gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation and early 
embryogenesis. Total reads and polyA reads are shown in charcoal and orange, 





























Figure 4.6 Genome snapshot of AURKA gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.7 Genome snapshot of MOS gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.8 Genome snapshot of H1FOO gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.9 Genome snapshot of ZP1 gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.10 Genome snapshot of ZP2 gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.11 Genome snapshot of ASTL gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.12 Western blot analysis showing increase of ZP2 protein levels from 
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Figure 4.13 PolyA differences during developmental stages. Log2 polyA count 
differences for the top 25 genes (selected by smallest FDR ﬁ ltering) from GV to 
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Figure 4.14  Genome snapshot of DPPA3 / STELLA gene. Figure shows up to 
the last four exons of the gene known to alter polyA during oocyte maturation and 
early embryongenesis. Total reads and polyA reads are shown in charcoal and 





























Figure 4.15 Genome snapshot of DPPA5 gene. Figure shows up to the last 
four exons of the gene known to alter polyA during oocyte maturation and early 
embryogenesis. Total reads and polyA reads are shown in charcoal and orange, 





























Figure 4.16 Genome snapshot of OOEP gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.17 Genome snapshot of TRIM28 gene. Figure shows up to the last four 
exons of the gene known to alter polyA during early embryogenesis. Total reads 
and polyA reads are shown in charcoal and orange, respectively, overlapping 


















































































































































































































































































































Figure 4.20 Genome snapshot of PCDC5 gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 






























Figure 4.21 Genome snapshot of PCNA gene. Figure shows up to the last four 
exons of the gene known to alter polyA during oocyte maturation. Total reads and 
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5.1  Human Sperm Methylome Changes with Age and Environmental Impacts
The genome in human sperm is tightly packaged and DNA is hypermethylated. 
Only developmentally poised promoters and enhancers are the notable exceptions 
where hypomethylation has been documented. In our study, we asked if the DNA 
methylome in sperm is static or if it does change over time during the physiological 
process of aging. Overall, our ﬁ ndings suggest that the vast majority of CpG 
methylation in sperm does not change. We noticed a small but statistically signiﬁ cant 
global increase in DNAme over time with a rate of >0.4% global DNAme increase 
per year (p<0.001).  In contrast to global DNAme increase, we identiﬁ ed regions 
that get hypomethylated over time in the human sperm genome. Remarkably, 
some these regions are associated with genes implicated in neuropsychiatric 
disorders, Dopamine receptor D4 (DRD4; ENSG00000170956) and tenascin XB 
(TNXB; ENSG00000168477)1. 
One question that needs to be answered is what marks these regions for 
loss of DNAme? Preliminary data associate regions that lose methylation with 
regions that retain histones in sperm. One might speculate that either the histone 
deposition in aging sperm or the histone aberrant histone modiﬁ cation may play 
a role in hypomethylation of these regions. Another question that remains to 
be answered is if these regions of hypomethylation will serve as enhancers in 
differentiated tissue. An interesting hypothesis is that regions losing DNAme in 
aging sperm serve as enhancers or other regulatory elements in neuronal cells. An 
important experiment would be to test the regions of hypomethylation functionally 
in neuronal cells. Recent advancements in induced pluripotent stem cell (iPS 
cell) generation and differentiation into active neurons2 might serve as a platform 
to manipulate the hypomethylated regions in iPS cells and test the function in 
subsequently differentiated neuronal cells. An alternative mechanism by which 
these hypomethylated regions could be affected is a change in the non-coding 
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RNA (ncRNA) repertoire. It is now well established that there is a link of ncRNA 
and DNAme deposition3,4. A hypothesis worth testing is that ncRNAs acting in 
cis to regions of hypomethylation in sperm are either less expressed or not fully 
processed. Sequencing small RNA and total RNA from human sperm comparing 
young and aged donor proﬁ les with each other could test this hypothesis. If there 
is a change detectable in these RNAseq datasets, an experiment manipulating 
the expression of these ncRNAs in mice could shed some light onto the function 
of the ncRNAs in respect to DNAme deposition in sperm. The ﬁ eld of aging 
effects and environmental inﬂ uences on the sperm methylome is still in its infancy. 
Recent advancements in targeted and reduced representation genome bisulﬁ te 
sequencing5-7 and DNAme array technology8,9 have enabled us to answer some of 
the questions, but it can still be quite cost prohibitive to analyze sufﬁ cient samples. 
Finally, we are planning to test the effects of DNAme altering agents on 
sperm and the offspring’s sperm. A drug used for chemotherapy, 5-aza-cytidine 
(5azaC), works by irreversibly binding to DNMTs, thus killing their enzyme 
activity10,11. Consequently, cells lose DNA methylation in a passive process, since 
the reduced availability of DNTMs after the cell division leads to loss of DNAme. 
This mechanism of DNAme inhibition has been successfully used to treat patients 
with leukemia or colon cancer12,13. However, the important question of 5azaC 
effects on sperm and the offspring remains to be answered. We are currently in 
the process of testing this concern by treating male mice with low, medium and 
high dose of 5azaC. We will test the effect on the sperm of the F0 generation for 
DNAme aberrations. Importantly, to track parent of origin effects in the offspring, 
we plan to cross the treated fathers to highly polymorphic females. This enables us 
to track the DNAme changes in an allele speciﬁ c manner, allowing us to pinpoint 
DNAme changes inherited from the father’s allele. If changes persist in the sperm 
of the offspring, then we will continue to track the transgenerational changes into 
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the F2 and possibly the F3 generation. 
This question is of particular interest since the sperm epigenome may be 
poised to guide early embryo development14,15. Consequently, elucidating the role 
of the very deﬁ ned DNA methylation proﬁ le in sperm in context of early embryo 
development is critical in furthering our understanding. Equally important is the 
setup of DNA methylation in oocytes. Recent advancements in single cell bisulﬁ te 
sequencing16,17 will help us understand the role of DNA methylation in oocytes. 
Similarly to alterations in sperm DNAme with 5azaC, an interesting question would 
be to test oocytes for resistance to 5azaC. It is paramount to understand if DNAme 
changes related to 5azaC exposure are permanent or if they will be completely 
repaired after recovery from 5azaC. 
These experiments will help educate and advice couples in respect to family 
planning, where at least one partner had to undergo 5azaC chemotherapy during 
cancer treatment. While bulk levels of 5mC will most likely recover after 5azaC 
treatment, it is important to understand if regions in the genome are exempt from 
this recovery and to what extend DNAme changes will manifest. Testing 5azaC 
exposure in female mice followed by recovery will give clues of the robustness of 
DNAme deposition in oocytes. If changes in DNAme persist after recovery from 
5azaC, then the next step would involve testing the transgenerational inheritance 
of said DNAme changes. Similarly to the 5azaC study in male mice, breeding 
with polymorphic mice will enable us to track alleles in a parent of origin speciﬁ c 
manner. 
In summary, DNAme changes in gametes and the inﬂ uences on offspring 
is a very important question to answer. Previous epidemiology studies suggested 
a major inﬂ uence of diet and malnutrition on the offspring from parents exposed 
to these abnormalities18,19. Consequently, it will be interesting to test drugs known 
to modify epigenetic factors in context of gametes and further, on offspring from 
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parents exposed to these drugs. Mouse models seem to be the clear choice for 
answering these important questions as well as patient samples before and after 
treatment with 5azaC.
5.2  Polyadenylation Changes in Oocytes and Early Embryos Can be     
Monitored and Tested using PANDA
In Chapters 3 and 4, we detailed a novel approach for investigating polyA 
changes in total RNAseq datasets. Previous studies in Xenopus and Drosophila 
established a detail mechanism by which polyA regulation occurs in the cytosol 
after the genome transitioned from active to an inactive state20-28. Cytosolic 
polyadenylation involves a sequence element in the 3’UTR of the transcript that is 
recognized by CPEB (cytosolic polyadenylation element binding protein)29-32. The 
challenge for the cell is to maintain and regulate RNAs during a time when no new 
transcripts are made. Further, the decision and timing for translating the loaded 
messages into protein is also critical for oocyte maturation as well as setting up 
early embryo development, with a high priority for instructing genome reactivation. 
There is currently no study detailing transcriptome wide polyA changes 
in maturing oocytes in mammals. One important reason is the limiting material 
available to study polyA changes in oocytes for example. Recent advancements in 
single cell RNA sequencing enabled researches to investigate transcript levels and 
compare them between single cells33,34. However, this method relies on oligodT 
selection which in turn biases against polyA presence at the RNA. Further, single 
cell sequencing involves polyA trailing on the 5’ end of the transcript, changing 
the naturally occurring polyadenylation sites completely. Fortuitously, we decided 
to prepare RNA library with a protocol that is independent of oligodT selection 
and instead uses random hexamer priming for the reverse transcription step in 
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the protocol. This library preparation method from Epicentre called TotalScript™ 
bases the ribosomal RNA depletion on a proprietary buffer, which skews the 
reverse transcription polymerase towards transcribing RNA with comparatively 
less secondary structure. For example, ribosomal RNAs, which represent vast 
majority of RNA transcripts (>90%) in the cell, contain extensive secondary 
structure and are hence less likely reverse transcribed under the aforementioned 
reverse transcription protocol. Further, the TotalScript™ kit uses a transposases 
(Tn5) enzyme that will fragment the library and add adapters using much less input 
DNA than any other commonly used method. Notably, the input amount of total 
RNA per sample can be as low as 5 ng. This is in stark contrast to total RNAseq 
with prior RiboZero™ treatment, which requires a minimum input of 100 ng total 
RNA. Taken together, the TotalScript™ library preparation method enabled us to 
create and sequence RNA from as low as 17 cells (MI phase) without biasing for 
the polyadenylation status of transcripts. 
The second part of our analysis involved a novel approach at identifying 
the polyA status of transcripts present at the oocytes stages as well as in the 
early embryo. Since the polyadenylation of transcripts is a posttranscriptional 
process, the reference genome will not harbor any information of these added 
adenines. While alignment programs (software that assigns genomic coordinates 
to sequenced transcripts) are able to ignore certain homopolymer occurrences, 
usually reads containing polyA will be thrown out of the analysis and classiﬁ ed 
as impossible to align. Hence, reads that could potentially be informative for the 
polyA status are usually discarded. To tackle this issue, we developed a software 
package called PANDA that will parse the raw sequencing reads for potential 
polyA. It saves these reads in a separate ﬁ le, creates a copy and trims the copy 
of polyA. Subsequently, the trimmed reads are then subjected to the alignment 
program to obtain genomic coordinates for all raw reads. The next step involves 
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the parsing of the aligned reads for polyA. As mentioned before, the original, 
untrimmed reads are saved in a separate ﬁ le, allowing for the assignment of 
the aligned reads to polyA, if the aligned read has a matching “original” read. 
The original read carries the information about the length of the polyA captured. 
This information is then saved and encoded into the SAM alignment ﬁ le as a 
dedicated polyA tag (At:i:lengthOfPolyA). The last step involves the comparison of 
each transcript’s polyA status between different conditions. Here we investigated 
different developmental time points and asked if any of the transcripts gained or 
lost polyA. The PANDA program ‘PolyADifferantialSeq’ works with polyA counts 
but also outputs the relative polyA length change. As shown and discussed in 
Chapter 3, polyA length and normalized polyA counts are very well correlated (r= 
0.794). This property also enables visualization of normalized polyA counts in the 
genome browser (see Chapter 4).
We applied PANDA to the human oocyte and early embryo development 
RNAseq data. Remarkably, we were able to identify >1800 transcripts that gained 
polyA in the oocytes from the GV to the MI stage with a false discovery rate of less 
than 10-5. When we analyzed transcripts that gained polyA with an FDR < 10-5, 
we noticed that previously identiﬁ ed transcripts critical in cytosolic polyadenylation 
were in the top 100 list of transcripts gaining polyA. Namely, Aurora A kinase 
(AURKA), MOS and CEPB were all part of mediating polyA gain and were 
previously shown to receive polyA gain themselves in Xenopus and Drosophila 
oocytes29,31,32. Moreover, proteins known to be essential for oocyte maturation and 
early embryo development exhibited the same polyA gain from GV to MI as seen 
for AURKA, MOS and CEPB. For example, OOEP, GDF9, ZP1, ZP2, DPPA3, DAZL 
and H1FOO are all proteins previously identiﬁ ed in oocyte maturation and early 
embryo development. H1FOO and DAZL were shown to gain polyA in maturing 
bovine oocytes but neither of the other proteins was previously reported in gaining 
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polyA at that stage. Since these proteins are essential for oocyte maturation and 
early embryo development, it is not surprising to see them gaining polyA. 
Here we showed for the ﬁ rst time a transcript wide polyA analysis in maturing 
oocytes of mammals. Moreover, we also identiﬁ ed a decrease in polyA from MI to 
MII stage for most of the same transcripts that gained polyA from GV to MI. This 
transcript wide resolution of polyA dynamics in oocytes has also not been reported 
before. We postulate that transcripts gaining polyA are subjected to translation 
but must be turned off afterwards, since resources are limited in the egg and new 
nutrients will only be replenished after the placenta has formed. Thus, it is essential 
for the oocyte to turn off translation after the appropriate amounts of proteins are 
produced. Notably, transcripts only important in oocyte maturation, such as the 
zona pelucida sperm receptor transcripts ZP1 and ZP2, are not only stripped of their 
polyA but are also degraded afterwards. In contrast, a protein known to protect the 
maternal genome from active DNA demethylation, Stella/DPPA3/PGC7, receives 
polyA from GV to MI, gets deadenylated from MI to MII, but the transcript levels 
remain stable all the way to the cleavage stage. We speculate that genes falling 
in the same class as Stella are also required for early embryo development and 
hence are kept around to conserve precious resources. We identiﬁ ed a third class 
of transcripts that exhibit the same polyA pattern as transcripts crucial for oocyte 
maturation and early embryo development. For example, TRIM6 and ZNF770 are 
part of this class, which also gain polyA from GV to MI and get deadenylated 
from MI to MII. This class of transcripts is completely understudied and nothing is 
known in context of oocyte maturation and early embryo development. Analogues 
to transcripts essential at these developmental time points (AURKA, DPPA3, etc.), 
we speculate that they are also important factors necessary for oocyte maturation 
and early embryo development. Future research into polyA changes during mouse 
late oogenesis may reveal paralogues genes that can then be tested for their 
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importance in oocyte maturation and early embryo development.
Lastly, we have observed a shortening of 3’UTR usage for transcripts 
expressed in oocytes. The shortening of the 3’UTRs is also accompanied by a 
shift in polyA site usage. Previous studies identiﬁ ed alternative polyA site usage or 
3’UTR shortening in context of U1 limitation. U1 is part of the splicing machinery 
and low cellular U1 levels are implicated in driving 3’UTR shortening during the 
splicing process. Interestingly, we observed low levels of U1 in human oocytes and 
an overall shortening of 3’UTRs. The Dreyfus group described this dependency 
previously in neuronal cells and coined the term telescripting35,36. A hallmark protein 
for neuronal activity is HOMER1, whose function is to modulate the depolarization 
of neurons. The short isoform only contains exons 1 to 5 as well as part of intron 
5, where it gets cleaved and polyadenylated. The short HOMER1 isoform acts as 
a dominant negative, blocking recruitment of the long HOMER1 isoform to the cell 
membrane36 The switch between the long and the short isoform is modulated by 
the presence of U1snRNP in neuronal cells. Remarkably, we identiﬁ ed the same 
isoform switch of HOMER1 and low U1 levels in human oocytes. After transcription 
is turned on again in the cleavage stage, U1 levels are increased and HOMER1 is 
made predominantly full length starting at the morula stage. While no function of 
HOMER1 is reported in oocytes, the effect of low U1 levels and shortened 3’UTR 
is also observed in human oocytes. We postulate that oocytes are optimized to 
deal with transcription and splicing under low U1 levels to produce transcripts with 
shortened 3’UTRs. A possible explanation would be that the shortened 3’UTRs 
lack miRNA and piRNA binding sites, thus stabilizing transcripts by protecting 
them from DICER or Argonaute dependent degradation until the genome becomes 
active again.  Future research will need to test this hypothesis in mice. 
104
5.3  Cancer and Neurobiology Could Beneﬁ t from PANDA Analysis
As mentioned before, polyA site usage and 3’UTR length is modulated in 
development as well as in neuronal cells. Recently, reports of alternative polyA 
usage and differential polyA were shown in different cancer settings37,38. The 
ﬁ eld is still in the process of understanding why it is beneﬁ cial for cancer cells 
to use polyA modulation similarly to oocytes and neuronal cells. One hypothesis 
is that the stability and the usage of tumorigenic transcripts are driven by 3’UTR 
shortening. It is important to note that a hallmark of cancer is to reuse developmental 
programs39,40, thus turning on pathways that were meant for early development but 
not for differentiated cells. Similarly, the use of shortened 3’UTRs and alternative 
polyA sites observed in oocytes might also adhere to this theme. 
Interestingly, neuronal cells also use the toolkit of cytosolic polyA regulation 
and 3’UTR shortening under limiting U1 levels41. It is thought that these features 
are necessary to regulate and adapt synapses, which can be up to 2 meters apart 
from the nucleus. Hence, spatial and temporal transcript regulation independent 
of novel transcription is critical when neuronal cells can span these enormous 
distances. Consequently, it is of great interest to the ﬁ eld of neurobiology to 
understand the transcriptome wide use of cytosolic polyA changes. 
With the development of PANDA, we demonstrated how this application could 
be used to investigate polyA changes in human oocyte maturation and early embryo 
development. In our opinion PANDA could be used to investigate transcriptome 
wide polyA changes in cancer and neurobiology. The only prerequisite is that RNA 
from either sample is sequenced for total RNA and is not subjected to oligodT 
selection. We showed that low amounts of RNA could be used for total RNAseq in 
conjunction with the TotalScript™ (Epicentre) library preparation. Transcriptional 
changes as well as relative polyA changes can then be analyzed using the USeq 
progams DRDS and PANDA, respectively.
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5.4  Perspectives and Future Direction
We showed that PANDA analysis could be used to identify transcripts 
changing their polyA status during human oocyte maturation and early embryo 
development. However, it is impossible to test these changes in human oocytes. 
Moreover, manipulations of proteins involved in cytosolic polyadenylation or 
transcript’s 3’UTR are also not feasible options in humans. Consequently, 
it would be interesting to test these ﬁ ndings in mice. Firstly, a total RNAseq 
dataset comparable to our human total RNAseq dataset would be necessary 
to test similarities of polyA regulation between humans and mice. Once that is 
established, transcripts 3’UTR could be altered by means of genome editing using 
CRISPR to test for the importance of the CPE for example. Also, proteins and 
kinases involved in modulating cytosolic polyadenylation could be tested for their 
necessity and sufﬁ ciency in mice. Further, timing and signals for the deadenylation 
process of transcripts from MI to MII could be tested using PANDA. In summary, 
applying PANDA to understand oocyte maturation and early embryo development 
in mice could provide key insights into a fascinating point in development when the 
material to work with is extremely limited. Alternatively, zebraﬁ sh oocytes are much 
easier to obtain compared to mouse oocytes. Once zebraﬁ sh oocytes are staged, 
they can also be subjected to the PANDA workﬂ ow. Recent advancements in 
genome editing prove also very useful for the work in zebraﬁ sh. Similarly to mouse, 
transcripts and proteins involved in cytosolic polyadenylation could be altered to 
check their importance in oocyte maturation and early embryo development. An 
important question in the ﬁ eld is the role of AURKA and CAMK2α phosphorylation 
of CPEB at Tyr147. Using PANDA, a transcriptome wide effect of polyA depending 
on each kinase could be teased apart. 
 In summary, PANDA has great potential in studying transcriptome wide 
polyA changes where the material is extremely limited. Further, since the workﬂ ow 
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does not involve a specialized sequencing protocol, it dramatically simpliﬁ es and 
thus lowers the bar for transcriptome wide polyA analysis.
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Alterations in sperm DNA methylation patterns at
imprinted loci in two classes of infertility
Saher Sue Hammoud, B.S.,a,b Jahnvi Purwar, B.S.,d Christian Pflueger, M.S.,d Bradley R. Cairns, Ph.D.,d,e
and Douglas T. Carrell, Ph.D.a,b,c
aAndrology and IVF Laboratories, Division of Urology, Department of Surgery, bDepartment of Physiology, and cDepartment of
Obstetrics and Gynecology, School of Medicine, and dDepartment of Oncological Sciences, Huntsman Cancer Institute,
University of Utah; and eHoward Hughes Medical Institute, University of Utah School of Medicine, Salt Lake City, Utah
Objective: To evaluate the associations between proper protamine incorporation and DNA methylation at
imprinted loci.
Design: Experimental research study.
Setting: Research laboratory.
Patient(s): Three populations were tested—abnormal protamine patients, oligozoospermic patients, and fertile
donors.
Intervention(s): The CpG methylation patterns were examined at seven imprinted loci sequenced: LIT1, MEST,
SNRPN, PLAGL1, PEG3, H19, and IGF2.
Main OutcomeMeasure(s): The DNAmethylation patterns were analyzed using bisulfite sequencing. The percent-
age of methylation was compared between fertile and infertile patients displaying abnormal protamination.
Result(s): At six of the seven imprinted genes, the overall DNA methylation patterns at their respective differen-
tially methylated regions were significantly altered in both infertile patient populations. When comparing the
severity of methylation alterations among infertile patients, the oligozoospermic patients were significantly
affected at mesoderm-specific transcript (MEST), whereas abnormal protamine patients were affected at
KCNQ1, overlapping transcript 1 (LIT1), and at small nuclear ribonucleoprotein polypeptide N (SNRPN).
Conclusion(s): Patients withmale factor infertility had significantly increasedmethylation alteration at six of seven
imprinted loci tested, with differences in significance observed between oligozoospermic and abnormal protamine
patients. This could suggest that risk of transmission of epigenetic alterations may be different with diagnoses.
However, this study does not provide a causal link for epigenetic inheritance of imprinting diseases, but does
show significant association between male factor infertility and alterations in sperm DNAmethylation at imprinted
loci. (Fertil Steril! 2010;94:1728–33. "2010 by American Society for Reproductive Medicine.)
Key Words: Imprinting, Beckwith-Wiedemann syndrome and epigenetic alterations, Angelman syndrome,
chromatin, assisted reproductive technology, IVF, ICSI, oligozoospermic, protamines
Genomic imprinting is established and inherited during gametogen-
esis and preimplantation to ensure parent-of-origin monoallelic
gene expression (1, 2). The mechanism by which either one of the
two alleles are differentially expressed is not completely under-
stood; however, it is known that the majority of imprinted genes
are clustered and are predominately regulated by imprinting control
regions (ICRs) (3, 4). At present, approximately 80 imprinted genes
have been identified, many of which are implicated in tumorigene-
sis, fetal growth regulation, and embryonic development (5–8).
Pathological perturbation in the methylation imprints during game-
togenesis or development can give rise to growth-related syndromes
and is frequently observed in cancer (9–20).
After fertilization, both parental genomes are globally demethy-
lated through active or passive demethylation mechanisms, whereas
the methylation patterns at imprinted genes are maintained and only
erased and re-established in the primordial germ cell. The presence
of abnormal methylation patterns residing in gametes raises con-
cerns, as these may be inherited and maintained in the embryo.
Meta-analysis showed that children born from assisted reproductive
technology (ART) have a fourfold increased incidence of Beckwith-
Weidemann syndrome compared with children conceived naturally
(21–24). In addition, imprinting syndromes such as Angelman,
Prader-Willi, and Silver-Russell have been associated with ART,
although no strong correlations were established. Currently, it is un-
clear whether imprinting abnormalities arise from the ART proce-
dure itself or from pre-existing methylation aberrations in the
gametes of infertile patients (25–27).
Recent studies have shown that epigenetic abnormalities are com-
mon in the sperm of severely oligozoospermic patients, favoring the
latter hypothesis (26, 27). Whether epigenetic alterations at im-
printed loci of infertile men are limited to oligozoospermic patients
or whether epigenetic alterations extend beyond oligozoospermic
patients is unknown. In this study we examine methylation changes
in patients with an alternative cause for their male factor infertility—
patients with abnormal sperm protamine replacement of histones.
Protamines 1 and 2 are sperm-specific nuclear proteins that are in-
corporated into the DNA in a 1:1 ratio and ensure chromatin
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condensation. The average P1:P2 ratio in fertile men is!1, whereas
in some infertile patients this ratio is significantly altered (28, 29)
and consequently associated with severe sperm defects that can usu-
ally be addressed through ART (30, 31). It has been proposed that
chromatin packaging may have a role in properly establishing and
maintaining methylation patterns, hence, hypothetically, patients
with abnormal protamine ratios may be at an increased risk of con-
ceiving an ART offspring with imprinting disease (32, 33). This
study evaluates the relationship between protamine ratios and meth-
ylation patterns at seven imprinted loci in the sperm of abnormal
protamine patients or oligozoospermic patients. We reveal signifi-
cant changes in the overall DNA methylation patterns at six of these
loci, with varying impact on methylation patterns within each class
of infertility: oligozoospermic or abnormal protamine levels
(p-value< 0.05, Figure 1). These data suggest that aberrant imprint-
ing patterns are observed in patients with abnormal protamine ratios,
and that the abnormal patterns may vary among different patholo-
gies, providing a spectrum of risks for transmitting epigenetic abnor-
malities to the embryo.
MATERIALS AND METHODS
Patient Population
Of the seven tested imprinted loci, six are paternally demethylated and ex-
pressed: KCNQ1 overlapping transcript 1 (LIT1), insulin-like growth factor
2 (IGF2), paternally expressed gene 3 (PEG3), pleiomorphic adenoma gene-
like 1 (PLAGL1 also known as ZAC), small nuclear ribonucleoprotein
FIGURE 1
The overall methylation patterns at both paternally and maternally imprinted genes were altered in the sperm of infertile patients. (A,B,C) The
mean percentage of methylation with standard error. P< .05 is significant. (A) The percentage of methylated CpGs at normally paternally
demethylated loci. (B) The percentage of demethylation at a paternally methylated DMRofH19. (C) Comparingmethylation changes between
the two infertile patient populations. (D) Methylation status at the differentially methylated region of LIT1 for fertile donors, oligozoospermic
patients, and abnormal protamine patients.
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polypeptide N (SNRPN), and mesoderm-specific trancript (MEST), and one
is maternally expressed and is normally DNA methylated in sperm (H19).
For each locus 10 oligozoospermic (sperm count%10" 106/mL), 10 abnor-
mal protamine replacement patients (average sperm count of 73 " 106 # 60
SD/mL), and 5 known fertile donors were evaluated. For LIT1 only, eight oli-
gozoospermic patients and nine abnormal protamine patients were evaluated.
Sample Collection and Bisulfite Treatment
Institutional Review Board (IRB) approval was obtained before initiation of
this study. Frozen sperm DNA samples were treated with sodium bisulfite to
convert unmethylated cytosines to uracil and leaving methylated cytosines
unchanged, as previously described by Clark et al. (34). DNA was purified
using Qiagen DNeasy clean up kit (Qiagen, Valencia, CA) and eluted twice,
each time with 100 mL of elution buffer. The purified DNAwas desulfonated
by the addition of 20 mL NaOH and incubated at 37$C for 15 minutes. After
incubation, 22 mL of 4 M NaOAC, glycogen, and two volumes of ethanol
were added to precipitate the DNA overnight at -20$C. Precipitated DNA
was washed twice with 70% ethanol and eluted in 30 mL of elution buffer.
PCR Amplification of Bisulfite Converted DNA
Primer sequences and temperatures for SNRPN, PEG3, ZAC, MEST, LIT1,
H19 ICR, and IGF2 are available upon request (35, 36). The polymerase
chain reaction (PCR) reactions were performed in 50-mL volume reactions
containing 5 mL of 10 " PCR buffer–MgCl2 (Invitrogen, Carlsbad, CA), 5
mL of 10 " Enhancer Buffer (Invitrogen), 1.5 mL of MgCl2, 1 mL of 10
mM dNTPs, 0.5 mL of Taq (Invitrogen), 2.5 mL of each forward and reverse
primer (10 mM stock), and 30 mL of water. The PCR results were analyzed on
a 1% agarose gel, and gel purified if multiple products were detected.
TOPO TA Cloning and Sequencing
The PCR products were cloned into a TOPO 2.1 pCR vectors (Invitrogen)
and plated onto KAN-X-GAL plates for blue-white screening. Positive col-
onies were reinoculated into LB-KAN (50 mg/mL), cultured overnight, and
plasmids were purified using the Qiagen 96-well clean-up kit. To address
sperm sample heterogeneity five or more clones/alleles were sequenced
per patient for each of the imprinted loci (sequencing done at Genewiz San
Diego Laboratory).
Data Visualization and Analysis
The CG/TG-analyzer, a Perl program, was used to examine the methylation
status of a bisulfite-converted sequence and provides an output in the form of
1s and 0s, where 1s represent methylated cytosines and 0s represent unme-
thylated cytosines (thymine). The CpG positions were defined in a multifasta
file, text-based file containing multiple DNA or protein sequences, which in-
cludes the CpG position number flanked by four nucleotides on each side.
The output was used to calculate the percentage of CpG methylation
(program is be available upon request). To compare the overall methylation
profile in infertile patients versus fertile donors (Fig. 1), theWilcoxon-Mann-
Whitney test was used. This test is a nonparametric significance test for as-
sessing whether two independent samples of observations came from the
same distribution. To determine significance between fertile donors and oli-
gozoospermic patients or fertile and abnormal protamine patients the per-
centage of methylated CpGs represented in columns 2 and 3 (in Tables 1,
2, and 3) were compared as independent sample populations. A P value
< .05 was considered significant. The c2 analysis was used to compare the
percentage of methylated CpGs in the abnormal protamine or oligozoosper-
mic patients with known fertile donors.
RESULTS
Six imprinted genes, that are normally paternally demethylated,
were examined: LIT1, SNRPN, MEST, ZAC, PEG3, and IGF2.
Here, all except IGF2, showed significant hypermethylation in
oligozoospermic and abnormal protamine patients compared with
fertile donors (Fig. 1A). Furthermore, the differentially methylated
region (DMR) of H19 (a paternally methylated locus) was
TABLE 1












CpG 1 25.882 18.181 0 0.0003 0.0035
CpG 2 20 18.181 0 0.0021 0.0035
CpG 3 20 10.909 0 0.0021 0.0271
CpG 4 20 10.909 2.38 0.0066 0.17
CpG 5 21.176 10.909 0 0.0015 0.0271
CpG 6 20 10.909 0 0.0021 0.0271
CpG 7 21.176 10.909 0 0.0015 0.0271
CpG 8 20 10.909 0 0.0021 0.0271
CpG 9 20 10.909 0 0.0021 0.0271
CpG 10 20 10.909 0 0.0021 0.0271
CpG 11 21.176 12.277 0 0.0015 0.0186
CpG 12 20 10.909 0 0.0021 0.0271
CpG 13 21.176 10.909 0 0.0015 0.0271
CpG 14 20 14.454 0 0.0021 0.0101
CpG 15 20 10.909 0 0.0021 0.0271
CpG 16 20 7.272 0 0.0021 0.0742
CpG 17 20 10.909 0 0.0021 0.0271
CpG 18 21.176 12.272 0 0.0015 0.0093
CpG 19 20 10.909 0 0.0021 0.0271
CpG 20 20 10.909 0 0.0021 0.0271
CpG 21 21.176 16.363 0 0.0015 0.0059
CpG 22 21.176 16.363 0 0.0015 0.0059
Note: DMR ¼ differentially methylated region.
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significantly hypomethylated in both infertile classes (P<.006 for all
except ZAC, P<.002) (Fig. 1B). Thus, these infertile patients show
methylation alterations at six of seven loci tested. However, when
comparing overall methylation changes between the two infertile
populations, abnormal protamine patients show more extensive
hypermethylation at the DMRs of LIT1 and SNRPN in comparison
with oligozoospermic patients. In contrast, hypermethylation at
MEST is significantly higher in oligozoospermic patients (p-value
< 0.006, Fig. 1C).
Notably, in both patient populations, the locus that displays the
highest number of affected CpGs is LIT1. In the DMR of LIT1,
the percentage of methylated CpGs ranged from 7%–18% or
20%–25% for oligozoospermic or abnormal protamine patients, re-
spectively (Table 1). In contrast, for fertile donors, virtually all CpGs
were demethylated. The percentages of methylated CpGs in oligo-
zoospermic and abnormal protamine patients were statistically
significant when compared with fertile donors (p-value < 0.05,
Table 1). To address the uniformity of methylation changes at
LIT1 in individual sperm from a single patient, we sequenced mul-
tiple alleles (5–12) from each patient, and found striking heteroge-
neity. In three of the eight oligozoospermic patients, LIT1 was
completely methylated in 20%–30% of the alleles, whereas in
the other five patients, only sporadic increases were observed
(Fig. 1D). Similarly, in the abnormal protamine category one
patient always displayed complete methylation, a second displayed
methylation on 50% of his alleles, and the remainder (seven)
displayed little or no increase.
Consistent with the findings reported previously, the DMR of
SNRPN was also susceptible to acquiring methylation in infertile
men. Abnormal protamine patients had a significant increase in
CpG methylation (methylation at individual CpGs typically ranged
from 4%–20%) (p-value < 0.05 Table 2). Alterations were also
observed in oligozoospermic patients (range of methylation,
4%–8%), but the increase lacked statistical significance (Table 2).
At SNRPN, alterations in methylation were common (observed at
a majority of the alleles) but typically involved only a moderate
number of CpGs acquiring methylation. However, in both patient
categories, a small number of patients displayed complete methyla-
tion at 10% of the alleles tested.
Methylation levels in the DMR of MEST (for each CpG) ranged
from 7%–19%or 1%–3% in oligozoospermic or abnormal protamine
patients, respectively (Table 3). The changes in methylation at many
of the CpGs in oligozoospermic patients were near the range of statis-
tical significance (P¼.07; Table 3). In addition, 3 of 10 oligozoosper-
mic patients had 12%–33% of their alleles completely methylated,
whereas the remaining 7 patients displayed very little change. Like-
wise, in the abnormal protamine class, one patient had 14% of his al-
leles completely methylated and in the remaining nine patients, there
was virtually no change observed. In contrast, very few individual
CpGs were significantly (P<.05) affected in PEG3, ZAC, IGF2 pro-
moter 3, and H19 in infertile patients (data not shown).
DISCUSSION
In this study we evaluated the methylation status of seven imprinted
loci in two patient populations: oligozoospermic and abnormal prot-
amine ratio patients. The overall methylation patterns in sperm of in-
fertile patients were significantly altered at all imprinted loci (except
IGF2) when compared with fertile donors. However, when compar-
ing the two infertile patient populations, oligozoospermic patients
were hypermethylated at MEST, an imprinted gene associated with
Silver-Russell syndrome, whereas abnormal protamine patients
had significant changes at LIT1 and SNRPN (Figure 1), genes that
may be associated with cases of transient neonatal diabetes mellitus
and Angelman syndrome. These data suggest that risk of transmis-
sion of epigenetic alterations may be different with diagnoses.
TABLE 2












CpG 1 4.3 4.0 0 0.152 0.169
CpG 2 5.8 5.0 0 0.09 0.123
CpG 3 5.8 5.0 0 0.09 0.123
CpG 4 5.8 5.0 0 0.09 0.123
CpG 5 5.8 5.0 0 0.09 0.123
CpG 6 10.6 5.0 0 0.026 0.123
CpG 7 14.8 8.0 4.3 0.08 0.413
CpG 8 8.7 5.0 0 0.04 0.123
CpG 9 13.0 5.0 4.3 0.10 0.864
CpG 10 23.1 16 6.5 0.05 0.114
CpG 11 10.1 6.0 0 0.026 0.09
CpG 12 11.6 6.1 8.7 0.618 0.526
CpG 13 15.9 8.0 6.5 0.1 0.753
CpG 14 47.8 10 2.2 0.0001 0.09
CpG 15 11.6 6.1 0 0.017 0.08
CpG 16 5.8 4.0 2.2 0.351 0.566
CpG 17 11.6 13 2.2 0.065 0.039
CpG 18 15.9 12.2 6.5 0.130 0.295
CpG 19 15.9 5.1 6.7 0.140 0.705
CpG 20 17.4 5.1 0 0.003 0.119
CpG 21 17.6 4.1 2.2 0.011 0.560
Note: DMR ¼ differentially methylated region.
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Our data evaluate and demonstrate abnormal imprinting in a dif-
ferent class of abnormal spermatogenesis, abnormal replacement of
nuclear proteins by protamine 1 and protamine 2. It was our hypoth-
esis that abnormal chromatin packaging may be associated with
methylation defects, which is supported by the data presented
from this study. These data, along with previously published data
from oligozoospermic patients, reveal that alteration in DNA meth-
ylation patterns are common at a handful of imprinted loci tested,
suggesting that imprinting abnormalities may reside in the sperm
of infertile patients (25–27), but whether these alterations can be in-
herited is uncertain. Remarkably, when examining normally deme-
thylated DMRs, the alleles of infertile patients are often either
unaffected or entirely methylated, suggesting a bistable status, and
a susceptibility to complete methylation. Clearly, complete methyl-
ation of a normally unmethylated locus may lead to an imprinting
disorder in the embryo if proper imprint reestablishment mecha-
nisms are not implemented. Also of note are the small differences
in the degree of methylation within some genes and alleles. It is im-
portant to determine whether this abnormal methylation has reached
a threshold level that might lead to complete methylation in the
embryo (at a certain unknown probability) and confer disease, or
whether there is a gradual continuum with a threshold for disease.
Whether imprinting diseases in ARToffspring arise as a result of
abnormal methylation of gametes, or acquire methylation changes
during in vitro culture, or both, is still unknown. Current human
data suggest that methylation alteration at imprinted loci may reside
in gametes and may be inherited by the embryo. Supporting evi-
dence comes from two reports showing that a gain in methylation
on the paternal alleles of LIT1 or MEST in sperm is maintained in
the baby and associated with transient neonatal diabetes (37) or
Silver-Russell syndrome (38). The findings suggest that paternal
imprints in sperm may be needed for a healthy and uncomplicated
pregnancy. The need to study sperm from fathers of children with
imprinting diseases is imperative.
This study does not report a causal link between abnormal meth-
ylation of imprinted genes and disease. The relative risk of the
defects reported in our study to patients is unknown. However, we
demonstrate a link between abnormal spermatogenesis and abnor-
mal methylation of genes associated with rare imprinting diseases
previously reported to have elevated incidences in ART offspring
(21–24). This suggests that such a link may be strengthened in infer-
tile men with known abnormalities in chromatin packaging. Charac-
terizing these epigenetic alterations in the sperm of infertile men
may help predict the likelihood of IVF success rate.
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7APPENDIX B
TO  ELIMINATE SOMATIC CELL CONTAMINATION FROM                      
HUMAN SPERM PREPARATIONS
119
B.1  Experimental Design
Goal: To test if somatic cell contamination in sperm preparation can change 
DNA methylation levels at a selected imprinted locus and to establish a protocol to 
eliminate any such somatic cell contamination.
1) Establish a stringent somatic cell lysis protocol that yields high sperm 
recovery but lacks somatic cell contamination:
2) To test for effectiveness of this somatic cell lysis (SCL) protocol and 
compare it to a previously published SCL protocol from the Carrell lab:
Test for DNAme levels at the imprinted, DNA hypomethylated DLK1 
promoter:
a) Human sperm
b) Human white blood cells
c) Known contamination levels of white blood cells to human sperm
a. Test performance of Carrell lab SCL protocol
b. Test performance of Christian Pﬂ ueger’s SCL protocol
B.1.1  Sperm Incubation Buffer
MEM media (Minimum Essential Medium Eagle media) is used at room 
temperature and 0.4% w/w BSA (Bovine Serum Albumin) is added. To ensure 
proper buffering, 10x PBS (Phosphate Buffered Saline, pH 7.4) is added to 1x 
concentration. For each sample, approximately 5 ml buffer is required. For ten 
samples, 45 mL of MEM are mixed with 2 mg BSA and 5 ml 10x PBS are added 
afterwards. After complete resuspension of the BSA, the solution is ready to use.
B.1.2  Somatic Cell Lysis Buffer (2x concentrated)
For each sample, 4 ml 2x concentrated SCL is required. To obtain 2x SCL, 
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resuspend 0.2 % w/v SDS (Sodium Dodecyl Sulfate) and 1 % Triton X-100 in 
RNAse and DNAse free water.
B.1.3  Cell Strainer
Cell strainers for 50 ml conical tubes are required to ﬁ lter out bigger chunks 
of somatic cell contamination. 40 µm Nylon cell strainers from Fisher Scientiﬁ c, 
#08-771-1, were used.
B.1.4  Stainless Steel Beads for Qiagen Tissue Lyzer
Qiagen Stainless Steel Beads, 5 mm (200), # 69989, were used to lyze the 
sperm cells.
B.1.5  Protocol
Male mice were sacriﬁ ced according to IACUC regulations and the 
epididymis with the attached vas deferens was extracted and transferred to a small 
petri dish (20 mm by 5 mm) and a volume of 1 ml sperm incubation buffer is added 
to the sample. Further, the sperm is then squeezed out of the vas deferens with a 
small forceps and the epididymis is poked with the same forceps to create lesions 
for the sperm to swim out. The sample is then incubated for 1h at 37ºC. After the 
incubation, the sperm is pipetted up and down to ﬁ nalize separation of the sperm 
cells from each other. The sperm cells are then pipetted through the nylon 40 µm 
cell strainer into a 50 ml conical tube, followed by a 10 mL 1x PBS rinse. Then, the 
cell strainers are removed and the tubes capped, followed by a 10 min 2,000xg 
spin to pellet the sperm cells. The supernatant is subsequently removed, the sperm 
cells are resuspended in 40 ml 1x PBS and the samples are spun again for 5 min 
at 4780xg. This procedure is repeated once more. Then, the sperm samples are 
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resuspended in 40 ml water (RNAse and DNAse free) and followed by a 10 min 
spin at 4780xg. The subsequent removal of the water needs be done very carefully 
since the pellet will be very loose at that point. Ideally, about 0.8 to 1 ml of water 
was left to resuspend the pellet and maximize sperm recovery. The sperm samples 
are then transferred to a 15 ml conical tube and water is added to 4 ml. At this 
point, the 2x SCL buffer is added with 4 ml per sample for a total volume of 8 ml. 
The samples are then inverted roughly 5 times and incubated on ice for at least 1h 
to complete somatic cell lysis process. Then, the samples are spun down for 10 
min spin at 4780xg. The supernatant is removed but 100 to 200 µl of buffer is left 
back in order to resuspend the samples. This is to ensure maximum recovery of 
the sperm samples and to maximize yield of DNA and RNA subsequently. Samples 
are then transferred to a 2 ml safe lock tube and samples can be frozen and stored 
at -80ºC at this point.
B.2  Results and Discussion
Determining accurate DNA methylation levels for sperm samples is critical in 
understanding epigenetic alterations based on environmental inﬂ uences or disease 
relevance. Notably, small amounts of DNA from somatic cells can contaminate the 
DNAme analysis and lead to wrong interpretations. This issue was the motivation 
to develop a robust and stringent protocol to remove cells and thus DNA from 
somatic cells while saving the majority of sperm DNA for analysis. In order to 
measure DNAme alterations at a known DNA hypomethylated locus, we chose to 
investigate the DLK1 promoter by bisulﬁ te pyro sequencing. The DLK1 promoter is 
known to be hypomethylated in sperm and hypermethylated in somatic cells. The 
experimental setup was to test two different SCL protocols and compare them with 
each other under conditions of known white cell contamination. As seen in Figure 
B.1, clean sperm only has roughly 10% DNA methylation at the DLK1 promoter 
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as opposed to white blood cells (WBC), which almost reach 80% DNA methylation 
levels. Each sample has four replicates, obtained from four independent human 
donors. 
The ﬁ rst question was to address if DNA sticking to the outside of sperm 
cells or incomplete lysis of WBCs is contributing to an altered DNAme proﬁ le. 
As seen in Figure B.1, adding either 10% WBCs or 50% WBCs to sperm cells 
increases DNAme levels. However, adding just DNA from WBCs to sperm cells 
does not change the hypomethylated property of the DLK1 promoter. Importantly, 
these samples have not undergone any SCL procedure. Hence, we concluded 
that intact somatic cells could be the root of changed DNA methylation levels if not 
removed thoroughly.
The second question was to address and compare the established SLC 
procedure from the Carrell Lab (shown in red bars, ﬁ gure 1) to the SCL method 
detailed above (show in green bars, Figure B.1). Remarkably, the Carrell Lab’s 
SCL failed to remove somatic cell contaminations and showed almost a 3-4 fold 
increase in DNA methylation at 50% WBC contamination. This is in stark contrast 
to the SCL method we have developed where neither of the WBC contaminations 
altered the DNAme levels signiﬁ cantly. 
Going forward, this more stringent SCL protocol will be implemented as 
the current standard to prepare sperm samples for analysis from either mouse or 
human. It is worth mentioning that mouse sperm samples can only be efﬁ ciently 
obtained by sacriﬁ cing the male mouse. It involves a surgical procedure in order to 
extract the sperm samples from the mouse. This method inherently has many more 
somatic cells contaminating the sperm sample due to that surgery as opposed 
to sperm donations from humans. However, patients or donors with low sperm 
counts may also have a skewed ratio of sperm to somatic cells. Consequently, the 
implementation of this SCL protocol for any kind of sperm samples seems a very 
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important step in ensuring no somatic cells will contaminate and thus alter the DNA 
methylation analysis of select loci.
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Figure B.1 Comparison of somatic cell contamination levels using different 
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